A comprehensive review of stroke-related signaling pathways and treatment in western medicine and traditional Chinese medicine

Abstract

This review provides insight into the complex network of signaling pathways and mechanisms involved in stroke pathophysiology. It summarizes the historical progress of stroke-related signaling pathways, identifying potential interactions between them and emphasizing that stroke is a complex network disease. Of particular interest are the Hippo signaling pathway and ferroptosis signaling pathway, which remain understudied areas of research, and are therefore a focus of the review. The involvement of multiple signaling pathways, including Sonic Hedgehog (SHH), nuclear factor erythroid 2-related factor 2 (Nrf2)/antioxidant response element (ARE), hypoxia-inducible factor-1α (HIF-1α), PI3K/AKT, JAK/STAT, and AMPK in pathophysiological mechanisms such as oxidative stress and apoptosis, highlights the complexity of stroke. The review also delves into the details of traditional Chinese medicine (TCM) therapies such as Rehmanniae and Astragalus, providing an analysis of the recent status of western medicine in the treatment of stroke and the advantages and disadvantages of TCM and western medicine in stroke treatment. The review proposes that since stroke is a network disease, TCM has the potential and advantages of a multi-target and multi-pathway mechanism of action in the treatment of stroke. Therefore, it is suggested that future research should explore more treasures of TCM and develop new therapies from the perspective of stroke as a network disease.

1. Introduction

Stroke is a serious medical condition that occurs when brain tissue is damaged due to cerebrovascular accidents. Different types of stroke include ischemic stroke, cerebral hemorrhage, and subarachnoid hemorrhage, which are classified based on their causes and symptoms. Ischemic stroke, the most common type, occurs when brain tissue is damaged due to a lack of oxygen and nutrients caused by thrombosis, embolism, or systemic under perfusion. In contrast, a cerebral hemorrhage occurs when a blood vessel ruptures in the brain, resulting in tissue underperfusion. About fifteen percent of cerebral hemorrhages result from ruptured blood vessels, structural abnormalities of blood vessels, or post-hypertensive small vessel abnormalities. Subarachnoid hemorrhage, which accounts for about 5% of strokes, is primarily caused by ruptured saccular aneurysms (Dirnagl et al., 1999; Donnan et al., 2008).

Stroke, along with severe conditions such as ischemic heart disease, chronic obstructive pulmonary disease, and Coronavirus Disease 2019 (COVID-19), is a significant cause of mortality worldwide. The pathophysiology of stroke comprises multiple mechanisms, including inflammatory response, oxidative stress, apoptosis, angiogenesis, and autophagy (Krupinski et al., 1994; Dirnagl et al., 1999; Allen and Bayraktutan, 2009). The Global Burden of Disease study data indicates that the number of stroke cases increased to 12.2 million in 2019, which is a substantial rise of 70.0% in comparison to the total number of stroke cases recorded in 1990 (GBD 2019 Stroke Collaborators, 2021) In low-income countries, the age-standardized mortality rate for stroke is 3.6 times higher compared to high-income countries, and stroke also poses a greater burden in low-income countries. Moreover, the incidence of stroke exhibits regional disparities, as well as variations in age and gender distribution (GBD 2019 Stroke Collaborators, 2021; Vyas et al., 2021). Stroke can be treated with a variety of interventions such as anticoagulation, antiplatelet medication, blood pressure control, lipid reduction, thrombolysis, carotid endarterectomy, and stem cell transplantation, all of which can help reduce the risk of stroke and provide some relief to patients (O’Rourke et al., 2004; Donnan et al., 2008; Barthels and Das, 2020). Research on epidemiology and preventive medicine has suggested that maintaining appropriate levels of metal elements in plasma is crucial for reducing the risk of stroke. Studies have identified high concentrations of iron, copper, and selenium in plasma as risk factors for stroke development (Alim et al., 2019; Mirończuk et al., 2021; Shi et al., 2021; Zhang et al., 2021). Further research has confirmed that stroke occurrence, progression, and prognosis can be significantly affected by cell death resulting from iron-related mechanisms (Zhou et al., 2021). Selenium (Se) therapy has been found to mitigate the detrimental effects of stroke by targeting the three primary factors involved in iron-related cell death, namely lipid peroxidation, generation of reactive oxygen species, and iron metabolism (Alim et al., 2019).

The signaling pathways associated with stroke are intricate, comprehensive, and interconnected systems. The year 2011 witnessed the emergence of a new field of study known as cyber medicine (Barabási et al., 2011). Stroke rarely results from abnormalities in the product of a single gene target, but rather is a multifaceted outcome of complex network interactions (Qin et al., 2022). The main focus of this paper is the concept of “network disease”, which seeks to provide novel insights into the exploration of better drug targets. Stroke is a complex network disease that involves multiple signaling pathways, and relying solely on single-target Western drugs may not be effective in treating it or have side effects. The benefit of TCM and its formulations lies in their ability to provide a synergistic effect on multiple pathways and targets, making them effective in acting on various signaling pathways involved in stroke (Lou et al., 2022). This paper aims to explore the molecular mechanisms of stroke-related signaling pathways, provide an overview of the historical process, development, and relationship between each signaling pathway and stroke, and highlight the intricate and interconnected relationships among them. In addition, we will review the current status of TCM in improving and treating stroke through various molecular mechanisms such as angiogenesis, inflammatory response, and oxidative stress. TCM holds great potential for pharmacological studies of network diseases such as stroke.

2. Historical progression of stroke’s classical signaling pathways

2.1. Stroke related signaling pathways: historical progress and current research

Given the complex pathogenesis of stroke, this paper provides a macroscopic overview of its pathophysiological basis. The pathophysiological mechanisms that contribute to stroke include angiogenesis, oxidative stress, autophagy formation, inflammatory response, and apoptosis (as summarized in Supplementary Table 1). Next, we provide a summary and elaboration of stroke-related signaling pathways from various molecular mechanisms such as angiogenesis, oxidative stress, autophagy behavior, inflammatory response, cell proliferation, and apoptosis (as summarized in Supplementary Table 2). A summary diagram of stroke-related signaling pathways is shown in Figure 1. Supplementary Table 2 summarizes the historical process and research progress of signaling pathways related to different pathophysiological mechanisms of stroke. Understanding the historical development process of each signaling pathway related to stroke can enhance our comprehension of the research process and development status of a particular signaling pathway. Currently, scientific research tends to explore the correlation between two signaling pathways, as the signal axis can impact the occurrence, development, and treatment of stroke (Zhan et al., 2022). In recent years, due to the network disease characteristics of stroke, the potential crosstalk between a signaling pathway and other signaling pathways has been gradually uncovered (Lou et al., 2022).

FIGURE 1

2.2. From the historical process: the Hippo signaling pathway and iron death signaling pathway in stroke should be focused

Previously, we summarized Supplementary Table 2, which summarized the historical course of stroke-related signaling pathways. Since its discovery in 2017, ferroptosis, a newly identified programmed cell death (PCD) pathway, has shown a potential relationship with stroke (Dixon et al., 2012; Zille et al., 2017). The signaling pathways involved in ferroptosis mainly include lipid peroxidation, iron metabolism, and amino acid metabolism, which can affect the generation of reactive oxygen species (ROS). Ferroptosis has gained significant attention in the fields of neuroscience and medicine, and it is now considered an important area of research (Hirschhorn and Stockwell, 2019). Ferroptosis has been implicated in the development and progression of a range of diseases, including stroke. Inhibition of ferroptosis, a newly identified form of cell death, has been shown to reduce lesion damage to some extent and even improve prognosis. However, the existing research on ferroptosis, particularly in relation to stroke, is limited. Therefore, we highlight the significance of ferroptosis and draw attention to its importance in stroke-related signaling pathways.

The Hippo signaling pathway is known to play a crucial role in regulating cell behavior, growth, proliferation, and tissue homeostasis (Meng et al., 2016). The historical studies on this pathway are mainly focused on cancer, and it regulates organ regeneration and cell plasticity (Harvey et al., 2013). Regeneration is also very important for the prognosis of stroke, affecting tissue recovery and cell regeneration after stroke injury. Therefore, it is very important to study the role of this signaling pathway in stroke. Recently, the important role of Sonic Hedgehog signaling pathway in brain repair and functional recovery after stroke suggests that the regulation of Sonic Hedgehog signaling pathway is a potential strategy to extend the therapeutic window after stroke. The molecular mechanism of regulating the Hippo signaling pathway can affect ischemia-reperfusion injury (Jin et al., 2017; Gong et al., 2019, 2021). Therefore, we take it out of the historical process of stroke and emphasize the potential of this pathway in stroke with a lot of pen and ink, suggesting that new and more research should be carried out.

It is crucial to consider the aforementioned pathways, however, there is limited strong historical research on their specific mechanisms and effects in the treatment of stroke. Additionally, it has been revealed that ferroptosis has crosstalk with other pathways such as necroptosis and oxidative stres (Yan et al., 2021). Furthermore, there is a potential crosstalk between the Hippo signaling pathway and the ferroptosis signaling pathway (He et al., 2022). Therefore, in the following sections, we will provide a summary of the historical progression of the Hippo signaling pathway and the ferroptosis signaling pathway, their underlying mechanisms, the interplay between pathways, and their relationship to stroke.

2.3. Hippo signaling pathway and stroke: regeneration potential

2.3.1. Research history of Hippo signaling pathway

The Hippo signaling pathway, also referred to as the Salvador/Warts/Hippo (SWH) pathway, has gained attention as a research area in recent years. It was initially discovered in tissues of the fruit fly Drosophila melanogaster. The research history of Hippo signaling pathway is shown in Figure 2. The first crucial gene of the Hippo signaling pathway, known as Warts (Wts or Lats), was identified through genetic screening in 1995 in Drosophila. This gene encodes a protein serine/threonine kinase and acts as a newly identified tumor suppressor gene. Inhibition of its expression can lead to excessive proliferation and abnormal differentiation (Justice et al., 1995; Xu et al., 1995). Subsequently, in 2002, the Hariharan and Halder labs identified the second gene of the Hippo pathway, Sav. This gene contains two domains associated with the Wts gene and promotes apoptosis. Mutations in the Sav gene are associated with abnormal proliferation and cancer (Kango-Singh et al., 2002; Tapon et al., 2002). Since then, there have been several discoveries in the Hippo signaling pathway. For instance, the tumor suppressor Mat was found to interact with the Wts gene to enhance Wts kinase activity (Lai et al., 2005). Additionally, the Hpo gene encodes a Ste-20 family protein that links the Wts gene with the Sav gene to control growth (Harvey et al., 2003; Udan et al., 2003; Wu et al., 2003). Among them, the Sav gene can be phosphorylated by the Hpo gene to promote the interaction with the Wts gene (Pantalacci et al., 2003). Furthermore, the Yap gene was found in yeast hybridization, which makes up for the missing link of downstream transduction of the Wts gene to regulate the cell cycle and activate cell death regulators (Huang et al., 2005). The identification of Mat, Hpo, Yap, and other genes has enabled the linkage of previously identified pathway components, resulting in the discovery of the Hippo signaling pathway, which regulates organ size by controlling cell number. The pathway was first identified in Drosophila tissues, and more than 30 components have been identified through various studies. Research has advanced from the initial studies in Drosophila to studies in mammals, with the pathway being evolutionarily conserved, as the key molecules identified in Drosophila have homologous genes in mammals (Meng et al., 2016). The Hippo signaling pathway is crucial for maintaining the balance between cell apoptosis and proliferation (Harvey et al., 2003). Furthermore, the Hippo signaling pathway is involved in embryonic development, tissue regeneration, and the regulation of organ size (Grijalva et al., 2014; Elbediwy et al., 2016; Moya and Halder, 2019). The Hippo signaling pathway has been implicated in a wide range of diseases, including cancer and cardiovascular diseases, due to its important function (Moroishi et al., 2015; Zanconato et al., 2016; Zheng and Pan, 2019).

FIGURE 2

2.3.2. The key regulatory mechanisms of Hippo signaling pathway

The Hippo signaling pathway is regulated through a series of steps. In mammals, the pathway is activated by upstream membrane protein receptors in response to extracellular signals. These receptors are subsequently phosphorylated by a sequence of conserved kinases, which ultimately regulate the activity of downstream effectors, namely Yes-associated protein (YAP)/PDZ-binding motif (TAZ) (Meng et al., 2016). Upon activation, YAP/TAZ may relocate to the nucleus and engage with TEA domain family members (TEAD) 1-4, triggering the activation of downstream transcription factors and consequent transcriptional activation (Lian et al., 2010; Meng et al., 2016; Pobbati and Hong, 2020).

The regulatory mechanism of Hippo signaling is shown in Figure 3. The Hippo signaling pathway is stimulated by various upstream signals, including mechanical signals originating from cell contact (predominantly from the extracellular matrix or ECM), G protein-coupled receptors (GPCRs), stress signals, as well as signals linked to cell cycle, polarity, and structure (Yu et al., 2012; Meng et al., 2016; Zheng and Pan, 2019). A kinase phosphorylation cascade constitutes the core of the pathway through which these inputs are transmitted.

FIGURE 3

Two critical proteins, MST1 and its interacting protein LATS1/2, are involved in the kinase phosphorylation cascade that forms the central part of the Hippo signaling pathway (Lian et al., 2010; Meng et al., 2016). By interacting with LATS1/2, the MST1/2 protein contributes to the inhibition of cell proliferation and differentiation. The C-terminal SAV (Sav/Rassf/Hpo) domain of MST1/2, a serine/threonine kinase, can boost its activity when it forms a complex with the scaffold protein SAV1. Upon activation by specific molecules in cells, the MST1 protein forms a complex with LATS1/2, leading to the suppression of cell proliferation and differentiation and ensuring the continuity of the kinase phosphorylation cascade (Grijalva et al., 2014; Meng et al., 2016). The modulation of the MST1 and LATS1/2 proteins’ activities by the Hippo signaling pathway is pivotal in regulating cell growth and differentiation. The transcriptional coactivators Yes-associated protein (YAP) and PDZ-binding motif (TAZ) are the downstream effectors of the Hippo signaling pathway (Moya and Halder, 2019). YAP/TAZ have the ability to move back and forth between the nucleus and cytoplasm. In the absence of Hippo signaling pathway activity, YAP/TAZ relocate to the nucleus and serve as transcriptional coactivators by binding to DNA with TEAD 1-4. On the other hand, upon Hippo pathway activation, YAP/TAZ become phosphorylated and are prevented from entering the nucleus, which in turn promotes their function as transcriptional corepressors (Meng et al., 2016). The activation of the Hippo pathway leads to the suppression of YAP/TAZ function due to phosphorylation mediated by LATS1/2. Conversely, in the absence of Hippo pathway activity, YAP/TAZ become dephosphorylated and move to the nucleus, where they can engage with the transcription factors TEAD1-4 to trigger gene expression (Meng et al., 2016).

Normally, the Hippo signaling pathway proficiently manages cell growth and averts uncontrolled proliferation. Nevertheless, in specific instances, the pathway may lose its functionality, triggering abnormal growth and tumor formation. Various research studies have uncovered that the Hippo signaling pathway is frequently deactivated in tumor tissues, which facilitates cell proliferation and ultimately results in tumor advancement (Zheng and Pan, 2019). Enhancing our comprehension of the Hippo signaling pathway’s regulatory mechanisms could pave the way for innovative approaches to treat tumors (Lian et al., 2010; Elbediwy et al., 2016; Pobbati and Hong, 2020).

2.3.3. Molecular mechanisms of Hippo signaling pathway in stroke

The relationship between the Hippo signaling pathway and stroke is primarily centered around the two core targets of YAP/TAZ and MST1. While previous research has primarily focused on the role of the Hippo signaling pathway in regulating cell proliferation and differentiation in cancer, there is growing interested in its potential involvement in stroke (Zanconato et al., 2016). Recently, its therapeutic potential in cardiovascular diseases has been discovered (Dey et al., 2020). Microglial activation in the infarcted area following a stroke is a critical factor that can mediate oxidative stress-induced cell death (Davalos et al., 2005). After being recognized as a crucial pro-apoptotic factor in neuronal death triggered by oxidative stress, the emerging evidence of MST1’s potential participation in ischemia-reperfusion injury implies that it could be a potential therapeutic target for the treatment of neurodegenerative disorders (Li D. et al., 2018).

Siqi Zhao et al. established a correlation between cerebral ischemia-induced microglial activation and the Hippo/MST1 signaling pathway. They discovered that Src kinase functions as an upstream factor that facilitates this association (Zhao et al., 2016). Furthermore, YAP/TAZ, which is another key site within the Hippo signaling pathway, also appears to play an important role following a stroke (Zhao et al., 2016). Activation of YAP/TAZ by dexamethasone has been shown to reduce brain damage, and infarct size, improve neurological function and decrease blood-brain barrier permeability following a stroke (Gong et al., 2019). In a study by Luping Huang et al., it was found that XMU-MP-1 could induce the nuclear localization of YAP in astrocytes, resulting in reduced brain damage, decreased release of inflammatory factors such as Interleukin-1β (IL-1β) and Interleukin-6 (IL-6), and a decrease in astrogliosis (Huang et al., 2020). Other studies have demonstrated that verteporfin, a drug used in photodynamic therapy, can reduce Blood-Brain Barrier (BBB) permeability after stroke by inhibiting the nuclear expression of YAP. This helps to maintain BBB integrity and reduce brain damage (Gong et al., 2021).

2.3.4. Crosstalk between Hippo signaling and other signaling pathways

There is likely a crosstalk between the Hippo signaling pathway and other signaling pathways, such as the Wnt, Notch, and SHH pathways. Some of the most notable examples of pathway crosstalk are summarized below.

2.3.4.1. Crosstalk between Hippo signaling and Wnt signaling

The regulation of cell proliferation, differentiation, migration, and apoptosis relies significantly on Wnt signaling (Varelas et al., 2010). Wnt proteins serve as signaling molecules in this pathway, and the critical proteins and receptors involved include β-catenin, Dishevelled (Dvl), and Frizzled (Fzd) (Mccrea et al., 1991; Siegfried et al., 1994; Bhanot et al., 1996). The extranuclear negative regulator YAP can limit the activity of the Wnt/β-catenin signaling pathway by interacting with Dvl, modulating Glycogen Synthase Kinase 3 beta (GSK-3β) activity, and binding to β-catenin, affecting its nuclear translocation (Varelas et al., 2010; Tsai et al., 2012; Wang Y. et al., 2017). However, upon activation of the Wnt/β-catenin signaling pathway, β-catenin can evade degradation and inhibit TAZ degradation outside the nucleus, resulting in the co-accumulation of TAZ and β-catenin (Azzolin et al., 2012). Furthermore, through binding to the DNA enhancer located in the first intron of the YAP gene, the β-catenin / Transcription Factor 4 (TCF4) complex can trigger the expression of YAP, its downstream factor, in cells (Konsavage et al., 2012; Park et al., 2015). A study published in Cell has confirmed that YAP interacts with the Wnt/β-catenin signaling pathway, involving the transcription factor Thromboxane B5 (TXB5) and the beta-transducin repeat-containing protein E3 (b-TrCP E3) ligase (Azzolin et al., 2012, 2014; Tsai et al., 2012; Park et al., 2015).

2.3.4.2. Crosstalk between Hippo signaling and Notch signaling

The Notch signaling pathway is a crucial mechanism that governs cell differentiation and proliferation. This pathway holds immense significance in the field of biology, as it is responsible for regulating cell fate decisions and influencing embryonic development and stem cell differentiation (Andersson and Lendahl, 2014). By acting as a critical regulator of cellular differentiation, the Notch signaling pathway helps to ensure that cells develop into the correct types and that tissues and organs form correctly (Totaro et al., 2018). Several investigations have verified the substantial involvement of YAP1 in controlling the Notch signaling pathway in liver cancer. In particular, YAP1’s activation of Jag-1, the ligand responsible for instigating the Notch signaling cascade, has been demonstrated (Tschaharganeh et al., 2013). In addition, the conjugate of YAP and TEAD has also been found to exert regulatory effects on Notch signaling and other genes within the Notch signaling pathways (Yimlamai et al., 2014; Hansen et al., 2015).

Recent studies have shown that the activation of YAP/TAZ through mechanical cues, in conjunction with distant enhancers, can stimulate the expression of delta ligands and promote epidermal differentiation through the Notch signaling pathway. This process has a direct impact on the properties of somatic stem cells (SC), influencing their ability to differentiate and self-renew (Totaro et al., 2017). The interplay between YAP/TAZ and the Notch signaling pathway’s downstream effector is crucial in multiple biological processes, such as the development of hepatobiliary ducts, epidermis, and the pathogenesis of cancer (Totaro et al., 2018). Through its interaction with the Notch signaling pathway, YAP/TAZ influences cell fate decisions and regulates cellular proliferation, differentiation, and apoptosis, highlighting the complex interplay between different signaling pathways in various biological contexts. The emerging understanding of the role of YAP/TAZ and the Notch signaling pathway in various cellular processes underscores the need for further research into their mechanisms of action and potential therapeutic implications.

2.3.4.3. Crosstalk between Hippo signaling and SHH signaling

The SHH signaling pathway is accountable for specifying the body axis, arranging tissues and organs, and sustaining appropriate cell proliferation in tissues. By serving as a vital modulator of embryonic development, the SHH signaling pathway helps ensure the accurate differentiation of cells and the proper formation of tissues and organs (Varjosalo and Taipale, 2008). Recent studies have demonstrated that Yes-associated protein (YAP) is a target of oncogenic activation induced by the Sonic hedgehog (SHH) pathway (Fernandez et al., 2009). In cerebellar granule neuron precursors (CGNP), SHH signaling prompts the nuclear translocation of YAP1, which stimulates their proliferation (Fernandez et al., 2009) FoxO6^–/– mouse studies have shown that the loss of SHH is associated with Hippo signaling (Sun et al., 2018). Furthermore, YAP has been shown to upregulate the expression of SHH, thereby contributing to bronchial morphogenesis (Isago et al., 2020). The exploration of the complex interplay between the Hippo signaling pathway and other signaling pathways in stroke remains incomplete. Our research builds upon prior studies to scrutinize plausible mechanisms of crosstalk between the Hippo signaling pathway and other pathways in the context of stroke. We provide a map below illustrating potential crosstalk between the Hippo signaling pathway and Wnt, Notch, and SHH signaling pathways (Figure 4):

FIGURE 4

2.4. Ferroptosis signaling pathway and stroke: regulating cell death

2.4.1. Research progress on ferroptosis of new cell death

In 1980, Bannai et al. made a groundbreaking discovery by identifying the antiporter protein cystine/glutamate transporter (xCT/SCL7A11), commonly known as system xC^– (Bannai and Kitamura, 1980). Later on, Murphy’s research revealed that system xC- also has the potential to induce glutamate toxicity, a condition that damages brain cells and can lead to neurological disorders (Hirschhorn and Stockwell, 2019). Descriptions of the unique cell death caused by cystine deprivation, which is now known as ferroptosis, existed before its official naming. These descriptions included the role of reduced glutathione (Ratan et al., 1994), ceramide-induced non-apoptotic ROS-dependent cell death (D’Autréaux and Toledano, 2007), and the involvement of polyunsaturated fatty acids in glutathione peroxidase 4 (GPX4) knockdown-mediated cell death (Seiler et al., 2008). In 2003, Dolma et al. discovered that Erastin induces iron-dependent cell death (Dolma et al., 2003). In 2012, Dixon et al. officially identified ferroptosis as a distinct mode of cell death with unique mechanisms that differentiate it from traditional apoptosis (Dixon et al., 2012). Subsequently, Yang et al. identified GPX4 as a crucial target of ferroptosis (Yang et al., 2014). Acyl-CoA synthetase long-chain family member 4 (ACSL4) is recognized as a pivotal regulator of ferroptosis and is responsible for mediating sensitivity to this process (Doll et al., 2017). In 2019, James A. Olzmann, Marcus Conrad, and Jose Pedro Friedmann Angeli identified a new repressor of ferroptosis, Ferroptosis inhibitor protein 1 (FSP1) (Doll et al., 2019). Ferroptosis is thought to have a considerable impact on numerous diseases, such as neurodegenerative diseases, cardiovascular diseases, and cancer. As a result, scientists are investigating approaches to impede ferroptosis with the aim of creating potent therapeutic interventions. The research progress on ferroptosis of new cell death is shown in Figure 5.

FIGURE 5

2.4.2. Regulatory mechanisms of ferroptosis siganling pathway

Ferroptosis is an orchestrated process of cell death that encompasses various mechanisms and pathways, including iron metabolism, lipid peroxidation, and amino acid metabolism (Li J. et al., 2020; Zhang et al., 2021). The buildup of intracellular iron ions (Fe²⁺) can activate ferroptosis, underscoring its significance in the regulation of this process. Transferrin (TFRC) is a pivotal protein that facilitates the translocation of iron from extracellular to intracellular compartments and plays a crucial role in regulating iron-induced cell death (Yang and Stockwell, 2016; Li J. et al., 2020).

The cystine/glutamate antiporter xC- operates by exchanging glutamate with cystine in a 1:1 proportion. Nevertheless, excessive levels of glutamate can impede xC-’s function, inducing ferroptosis (Yang and Stockwell, 2016). Cystine is an indispensable component necessary for the biosynthesis of glutathione (GSH), a process catalyzed by glutamate-cysteine ligase (GCL) and glutathione synthetase (GSS). Nevertheless, curtailing xC-’s activity can diminish the uptake of cystine, ultimately impairing GSH synthesis (Yang and Stockwell, 2016; Zhang et al., 2021). As a consequence, the decrease in cystine uptake leads to a reduction in the activity of GPX4, an enzyme responsible for membrane lipid repair, as well as a decrease in the antioxidant capacity of cells. Ultimately, these effects promote the onset of ferroptosis (Zhang et al., 2021). Reactive Species-Generating Compound 3 (RSL3) is an influential ferroptosis elicitor that directly hinders the activity of GPX4, culminating in the diminished cellular antioxidant capability and buildup of reactive oxygen species (ROS), eventually instigating ferroptosis (Yang et al., 2014; Yang and Stockwell, 2016; Hirschhorn and Stockwell, 2019).

The quantity and distribution of polyunsaturated fatty acids (PUFAs) in a cell determine the degree of lipid oxidation and influence the occurrence of ferroptosis. Free PUFAs play a role in synthesizing lipid signaling molecules and are incorporated into membrane phospholipids. Following lipid oxidation, PUFAs transmit ferroptosis signals that induce cellular death (Hirschhorn and Stockwell, 2019; Li J. et al., 2020; Chen et al., 2021a). ACSL4 and lysophosphatidylcholine acyltransferase 3 (LPCAT3) are two critical enzymes involved in the synthesis and restructuring of PUFAs in membrane phospholipids (Doll et al., 2017; Chen et al., 2021a). These enzymes facilitate the incorporation of PUFAs into phospholipids, resulting in the formation of polyunsaturated fatty acid phospholipids (PUFA-PLs). PUFA-PLs are highly susceptible to free radical-induced oxidation, which is mediated by lipoxygenases (ALOXs). The oxidation of PUFA-PLs eventually leads to the breakdown of the lipid bilayer and disrupts membrane function, ultimately promoting ferroptosis (Hirschhorn and Stockwell, 2019; Li J. et al., 2020; Chen et al., 2021a).

2.4.3. Research progress on ferroptosis signaling pathway in stroke

Ferroptosis has gained significant attention in neuroscience and medicine and is now an important area of research (Hirschhorn and Stockwell, 2019). Research has indicated that ferroptosis inhibitors possess the potential to shield against degenerative brain illnesses such as Parkinson’s disease (PD), Huntington’s disease (HD), and Alzheimer’s disease (AD), alongside other types of neurodegenerative diseases and traumatic and hemorrhagic brain injuries (Stockwell et al., 2017; Hirschhorn and Stockwell, 2019; Zhang et al., 2021). Recently, there has been growing interest in the therapeutic potential of ferroptosis in treating heart disease and cancer (Chen et al., 2021a; Li N. et al., 2021).

Ferroptosis has been suggested to be linked to stroke, as the reduced blood supply to the brain during a stroke can lead to a depletion of intracellular iron ions (Fe²⁺), which may ultimately promote ferroptosis (Zhang et al., 2021). Additionally, The accumulation of intracellular reactive oxygen species (ROS) can be caused by a stroke, which can further promote ferroptosis. While the precise role of ferroptosis in stroke remains unclear, recent studies have suggested that inhibiting ferroptosis may help reduce stroke-related damage (Zille et al., 2017; Li Q. et al., 2017).

Several studies have shown the role and therapeutic potential of ferroptosis in stroke. For instance, ZILLE, M et al. demonstrated that both ferroptosis and necrosis markers were increased following in vitro and in vivo stroke, and the inhibition of these pathways led to increased cell survival (Zille et al., 2017). In their study, Yu Cui et al. showed that protecting against cerebral ischemia-induced ferroptosis can be achieved by knocking down ACSL4, a crucial enzyme that regulates the synthesis of PUFA. Conversely, the risk of cerebral ischemia was observed to increase with the overexpression of ACSL4 (Cui et al., 2021). The inhibitory effect of baicalein on ferroptosis has been demonstrated in two models—an in vitro model of oxygen-glucose deprivation/reperfusion (OGD/R) in HT22 cells, and a rat model of transient middle cerebral artery occlusion (tMCAO) induced by RSL3. Baicalein achieves this effect primarily by regulating the expression levels of GPX4, ACSL4, and ASCL3, which are key enzymes involved in ferroptosis (Duan et al., 2021). Astragaloside IV has demonstrated potential neuroprotective effects against ferroptosis induced brain injury after subarachnoid hemorrhage (SAH) by activating the Nrf2/HO-1 signaling pathway. This pathway reduces lipid peroxidation and increases antioxidant enzyme levels, including glutathione peroxidase 4 (GPX4). As a result, the reduction of lipid peroxidation can prevent ferroptosis from occurring (Liu Z. et al., 2022). Sikai Zhan et al. showed that Danhong injection has the potential to alleviate nerve cell ferroptosis after ischemic stroke in permanent middle cerebral artery occlusion (pMCAO) mice by activating the SLC7A11/HO-1 pathway (Zhan et al., 2022). The findings of these studies indicate that the targeting of ferroptosis may hold promise as a therapeutic strategy for treating stroke in the future.

2.4.4. Crosstalk between ferroptosis siganling pathway and other signaling pathways

Several cellular pathways, such as the AMPK, Wnt, and Hippo signaling pathways, may interact with ferroptosis, indicating a possibility of crosstalk between them.

2.4.4.1. Crosstalk between ferroptosis siganling and Wnt signaling

Currently, the connection between ferroptosis and Wnt signaling is not yet fully understood by researchers. However, studies suggest that there could potentially be an association between Wnt signaling and cell death, indicating a possible relationship between the two pathways. Specifically, research has shown that β-catenin may bind to the TCF4 transcription factor and activate the expression of GPX4 by binding to the promoter region of GPX4. This activation can then inhibit ferroptosis (Wang H. et al., 2022).

2.4.4.2. Crosstalk between ferroptosis siganling and AMPK signaling

The crosstalk between ferroptosis and the AMP-activated protein kinase (AMPK) signaling pathway has been extensively studied and established. Ferroptosis requires the phosphorylation of Beclin 1 (BECN1), and AMPK facilitates this process by directly activating the activity of BECN1. This activation leads to the initiation of autophagy, which subsequently inhibits ferroptosis by removing iron from the cell (Kang et al., 2018; Song et al., 2018). In a mouse model of renal ischemia/reperfusion injury, it was observed that activating AMPK during energy stress could reduce the pathological damage caused by ferroptosis and lower the levels of polyunsaturated fatty acids. Conversely, inactivating AMPK increased cell sensitivity to ferroptosis, suggesting the potential therapeutic significance of targeting the AMPK pathway in diseases related to ferroptosis (Lee et al., 2020; Li C. et al., 2020).

2.4.4.3. Crosstalk between ferroptosis siganling and Hippo signaling

YAP, a protein involved in the Hippo signaling pathway, plays a role in regulating the lipid peroxidation process of ferroptosis. It does so by acting on the ASCL4 target in the ferroptosis pathway, as well as through its action on NADPH Oxidase 4 (NOX4) (Yang W. H. et al., 2019; He et al., 2022). Although the intricate crosstalk mechanisms between ferroptosis and other signaling pathways in stroke have been sparsely investigated, our study delves into this area based on prior research. Our objective is to explore potential crosstalk mechanisms between ferroptosis and other signaling pathways in the context of stroke. The following is a map of potential crosstalk of signaling pathways between ferroptosis and Wnt, AMPK, and Hippo signaling pathways (Figure 6).

FIGURE 6

2.5. Stroke is supposed to be a network disease: a complex network of pathways

Stroke is a complex network disease. The relationship and crosstalk among the signaling pathways involved in stroke are intricate and multifaceted. Apart from the Hippo signaling pathway and ferroptosis, pathways such as Wnt, AMPK, and Notch also contribute to stroke pathology. Upon scrutinizing the interplay between ferroptosis, Hippo signaling, and stroke, it is clear that the stroke signaling pathway encompasses a complex network of signaling pathways that interact and cross-talk with each other. This phenomenon of crosstalk is also evident in the historical evolution of stroke signaling pathways (Huang et al., 2013). Individual signaling pathways in stroke are involved in multiple pathophysiologies. For example, the Rho/Rock, Wnt/β-catenin, NO, and Vascular Endothelial Growth Factor (VEGF) signaling pathways, which contribute to angiogenesis, also play a role in neurogenesis, cell proliferation, and cell apoptosis (Menet et al., 2020; Lu et al., 2021; Hu Y. et al., 2022; Wang H. et al., 2022). Similarly, the SHH signaling pathway, which is associated with oxidative stress, affects anti-oxidation, anti-apoptosis, and the promotion of neurogenesis and angiogenesis (Huang et al., 2013). The Nrf2/ARE signaling pathway, which is involved in oxidative stress, is also associated with the inflammatory response and exhibits cross-talk with the NF-κB signaling pathway (Ahmed et al., 2017). The signaling pathway of HIF-1α plays a role in stroke-related processes such as inflammatory response, angiogenesis, and neuroprotection (Cheng et al., 2014; He et al., 2021). Peroxisome proliferator-activated receptor gamma (PPAR-α) agonists have the potential to protect against excessive oxidative stress, inflammation, and apoptosis following stroke (Collino et al., 2006; Luo et al., 2006; Fong et al., 2010). The signaling pathway of NF-κB plays a role in processes related to the inflammatory and immune response, as well as apoptosis (Brand et al., 1996; Pahl, 1999). The Notch signaling pathway, commonly associated with cell apoptosis, has been found to be increasingly associated with organogenesis and angiogenesis (Campos et al., 2002; Ito et al., 2002). The Hippo signaling pathway regulates organ volume and affects tissue regeneration by controlling apoptosis (Moya and Halder, 2019). The signaling pathway of TGF-β1/Smad3 serves a dual purpose of regulating both cell proliferation and apoptosis. In addition, it also holds significant importance in several physiological processes, including but not limited to inflammation, tissue repair, and the onset of cancer (Kang et al., 2009; Gough et al., 2021). The star signaling pathways in stroke, including the PI3K/AKT, JAK/STAT, AMPK, and MAPK pathways, play a role in angiogenesis, apoptosis, inflammation, autophagy, and oxidative stress (Jiang S. et al., 2018; Shariati and Meric-Bernstam, 2019; Arnold et al., 2021; Li N. et al., 2021). These pathways have multiple downstream targets and crosstalk with other pathways, contributing to various functions in stroke. Hence, exploring the mechanisms of these signaling pathways in stroke is crucial as they hold potential for treating stroke.

Secondly, taking individual signaling pathways as examples, it is also shown that there is a complex crosstalk relationship between stroke-related signaling pathways. The PI3K/AKT signaling pathway, considered a star pathway, participates in multiple functions such as oxidative stress, apoptosis, inflammation, and angiogenesis (Shariati and Meric-Bernstam, 2019). The mechanism of action is complex and involves a wide range of signaling pathways. Moreover, there are connections and crosstalk among the PI3K/AKT signaling pathway, HIF signaling pathway, and angiogenic NO signaling pathway (Ho et al., 2012; Szabo, 2017). Additionally, activated AKT has been found to protect against oxidative damage after stroke through the Nrf2/ARE pathway (Chan, 2005). The PI3K/AKT signaling pathway activation can inhibit the expression of pro-inflammatory factors stimulated by NF-κB, thereby reducing the inflammatory response (Xian et al., 2021). Studies have demonstrated that the PI3K/AKT signaling pathway promotes VEGF production, which induces angiogenesis after a stroke. Additionally, the activation of mTOR, a downstream target of PI3K/AKT, inhibits autophagy via the PI3K/AKT/mTOR signaling pathway (Chen J. et al., 2019; Yang et al., 2021). The Nrf2 signaling pathway, involved in oxidative stress, exhibits possible crosstalk with the MAPK and PI3K/AKT signaling pathways (Alfieri et al., 2011). The Notch signaling pathway has the potential for crosstalk with various other signaling pathways, including but not limited to Wnt, TGF-β/BMP, GSK-3β, Ras/MAPK, and autophagy signaling pathways (Hansson et al., 2004; Andersson et al., 2011; Sarin and Marcel, 2017). Stroke-related signaling pathways can affect other pathways through various axes, suggesting that stroke is a network disease with complex cellular signaling mechanisms.

Finally, the complex crosstalk relationship between signaling pathways forms a network of stroke signaling pathways. For example, in stroke, taurine can reduce ferroptosis after subarachnoid hemorrhage by affecting the crosstalk between the GABA/AKT/GSK3β/β-catenin axis and the Wnt and ferroptosis signaling pathways (Liu C. et al., 2022). Additionally, artesunate can inhibit the inflammatory response after ICH through the AMPK/mTORC1/GPX4 pathway by affecting the crosstalk between the AMPK signaling pathway and the ferroptosis signaling pathway (Xie et al., 2023). However, few experimental studies have investigated the crosstalk of the Hippo signaling pathway in stroke, which is a potential area of crosstalk that requires further investigation. Meanwhile, even though the crosstalk study of other signaling pathways has not been conducted in stroke, it demonstrates the complexity of signaling pathways in the human body. For example, the PI3K/AKT signaling pathway affects stroke through various pathophysiological mechanisms, such as oxidative stress, apoptosis, inflammation, and angiogenesis, and these pathways are not affected alone but overlap with each other (Shariati and Meric-Bernstam, 2019). When western drugs are used to treat stroke, they often target a single signaling pathway, which can lead to crosstalk between multiple pathways and affect only one aspect of stroke, such as inflammatory response or angiogenesis, without addressing the various pathophysiological mechanisms of stroke (Rikitake et al., 2005; Zacharek et al., 2009). This can result in poor therapeutic outcomes and potential side effects. In contrast, TCM has the characteristics of targeting multiple pathways and can act on stroke from multiple angles (Lou et al., 2022). Therefore, in proposing that stroke should be viewed as a network disease, new therapies need to be explored. Traditional Chinese medicine has the potential to play a multi-effect role in the treatment and improvement of stroke due to its multi-target and multi-pathway action. Research has shown that Compound Tongluo Decoction can inhibit endoplasmic reticulum stress and blepharoptosis, activate the SHH signaling pathway, and promote angiogenesis. This suggests that there may be potential crosstalk between the ferroptosis signaling pathway and the SHH signaling pathway in stroke (Hui et al., 2022). Although some scholars have proposed the network disease perspective for stroke, feasible evidence is still lacking (Lehnertz et al., 2023). Therefore, we have summarized the current status, advantages, and limitations of Western and traditional Chinese medicine in treating stroke, as well as the potential for combining these two approaches. Using the network disease perspective to view stroke can facilitate the development of new therapies, the discovery of the vast potential of traditional Chinese medicine, and the exploration of new possibilities for integrating traditional Chinese and Western medicine in stroke treatment.

3. Recent western medicine key treatment and trials of stroke

We summarize and outline the recent mature methods of western medicine in the treatment of stroke and the methods in the research stage. The prevention and treatment of ischemic stroke remains a challenging issue in the field of neurology. Advancing our understanding of the disease’s pathogenesis, developing effective treatment methods, and discovering novel drugs hold significant economic value and practical importance. Current clinical treatment options for stroke mainly focus on thrombolysis, antiplatelet and anticoagulant therapies, lipid-lowering medications, and non-surgical treatments such as alteplase and tissue plasminogen (tPA) administration, as well as surgical interventions like craniotomy thrombectomy and ventricular drainage (Donnan et al., 2008; Powers et al., 2019). Despite this, the existing western medicine treatment options still primarily rely on thrombolysis and vascular intervention.

3.1. Current existing clinical treatment methods of western medicine

Supplementary Table 3 summarizes the current clinical treatment methods for stroke, which primarily include intravenous thrombolysis, endovascular therapy, and drug therapy. Intravenous thrombolysis typically involves the use of alteplase, urokinase, and tirofiban. This method helps to reduce the incidence of stroke and increase blood perfusion in the ischemic area, but it carries a serious risk of bleeding. Additionally, the treatment time window for stroke is crucial in intravenous thrombolysis, as appropriate treatment timing plays a significant role in neurological recovery following a stroke (Wardlaw et al., 2014; Powers et al., 2019). The emergence of the third-generation thrombolytic enzyme, tirofiban, with a faster injection time and improved efficacy, poses a challenge to the primary clinical use of alteplase. However, its clinical application remains controversial due to a lack of sufficient clinical evidence to support its use (Singh et al., 2023). Mechanical thrombectomy is considered the preferred option for endovascular treatment, though the clinical effectiveness of arterial thrombectomy requires further evaluation (Hlavica et al., 2015). Drug therapy for stroke mainly consists of antiplatelet and neuroprotective medications. Aspirin and other antiplatelet drugs are limited in their efficacy due to the risk of bleeding, while the clinical effectiveness of neuroprotective drugs needs to be further evaluated in larger clinical trials (Greer, 2010; Martí-Carvajal et al., 2020). However, it is challenging to avoid the toxic side effects associated with drug therapy. For instance, edaravone is known to cause kidney and liver toxicity (Lapchak, 2010). Other treatments, such as oxygen therapy, anticoagulation, volume expansion, vascular dilation, and defibrination, have minimal evidence of effectiveness in treating stroke and are considered marginal treatments in clinical practice. Due to their limitations, these treatments are rarely used in clinical practice (Sandercock et al., 2008; Chang and Jensen, 2014; Powers et al., 2019). Figure 7 presents a summary of the historical evolution of key Western medical treatment approaches.

FIGURE 7

3.2. Current western drug treatment in the research and development stage

Supplementary Table 4 provides a summary of various western drugs for the treatment of stroke that are currently undergoing animal experiments or clinical trials. Among them, Fasudil, a Rock inhibitor, has shown promising results in reducing the area of cerebral infarction and is used to treat subarachnoid hemorrhage by targeting the Rho/Rock signaling pathway of angiogenesis in stroke (Rikitake et al., 2005; Shibuya et al., 2005; Shimokawa and Takeshita, 2005). Another drug, rosiglitazone (RSG), has demonstrated the ability to reduce the release of inflammatory factors and decrease the damage of recurrent stroke by activating PPAR-γ, but its clinical use is limited (Culman et al., 2007; Li et al., 2019). Metformin has demonstrated potential to reduce the risk of stroke by activating AMPK phosphorylation, suppressing NF-κB activation, and decreasing the levels of inflammatory factors such as IL-6, IL-1β, Tumor Necrosis Factor alpha (TNF-α), and Intercellular Adhesion Molecule 1 (ICAM-1) (Liu et al., 2014). Clinical drugs with specific pharmacological effects can have additional targets and sites of action, highlighting the importance of careful monitoring during clinical use to discover new applications that may improve therapeutic outcomes for patients with multiple diseases and reduce drug development costs. While Western medicine is frequently utilized for ischemic stroke treatment, it typically targets only one aspect of the disease and may have significant adverse effects. Despite the emergence of new drugs, few have been proven to be effective, and many Western drug trials focus predominantly on animal studies rather than clinical translation. Western medicine’s efficacy in treating stroke is limited, and it faces obstacles such as high research and development expenses, lengthy clinical trial periods, and restricted therapeutic benefits (Liu et al., 2018). Stroke is a multifaceted neurological disorder that involves numerous signaling pathways. As a result, Western drugs that target a single aspect of stroke have limited efficacy and often cause unwanted side effects.

4. Current TCM treatment improves and treats stroke through multiple targets and pathways

Ischemic stroke, from the perspective of TCM, falls under the category of “stroke”. It is considered a syndrome of deficiency of essence and standard, where the accumulation of phlegm and blood stasis and the obstruction of brain vessels are the main pathogenesis. Therefore, promoting blood circulation and removing stasis is the main treatment approach. TCM is known for its multi-target and multi-pathway treatment approach. By acting on multiple targets of stroke signaling pathways and affecting various pathophysiological mechanisms, it can exert multi-angle treatment and improvement effects (Chen S. et al., 2022; Lou et al., 2022). Chinese patent drugs like Danhong injection and Danqi capsule have shown promising results in the prevention and treatment of ischemic stroke. Acupuncture, another TCM treatment, has also shown potential in the treatment of ischemic stroke (Liu et al., 2018; Chen S. et al., 2022). TCM is gaining wide recognition and acceptance globally (Liu et al., 2018). During the outbreak of COVID-19, TCM played a significant role in epidemic prevention, treatment, and rehabilitation. The unique benefits of TCM in preventing and treating chronic and complex multifactorial conditions, especially in cardiovascular and cerebrovascular diseases such as stroke, have gained significant attention. With a mature theoretical foundation, TCM has shown promising clinical outcomes in the prevention and treatment of these diseases (Liu et al., 2018; Zhan et al., 2022). Supplementary Table 5 summarizes TCM, and their active components for the treatment and improvement of stroke. The following provides an overview of the research status of key TCM, such as Scutellaria baicalensis, Astragalus membranaceus, Rehmanniae radix, and their active components in the treatment of stroke. The treatment of stroke with key TCM and its active ingredients is shown in Figure 8.

FIGURE 8

4.1. Scutellaria baicalensis

Scutellaria baicalensis, also known as Scutellaria Baicalensis, is a Chinese medicine used for clearing heat and drying dampness. According to the Compendium of Materia Medica, it is used to treat various conditions, such as wind and heat, dampness and heat, headache, heat pain of running the dolphin, asthenia of lung, fishy throat, and blood loss. The plant contains baicalin, baicalein, astragaloside iv, and other compounds that have hemostatic and fetal safety properties. Baicalein, a flavonoid with the highest content in Scutellaria baicalensis, has been found to improve blood-cerebral circulation and possess anticoagulant properties. Studies by Li, M. et al. and Yang, S. et al. have demonstrated that baicalein can inhibit ferroptosis and neuronal apoptosis, reduce cerebral infarction area, and regulate signaling pathways such as GPX4/ACSL4/ACSL3 and NF-κB (Yang S. et al., 2019; Li et al., 2022). Baicalin, another flavonoid in Scutellaria baicalensis, has anti-thrombotic and anti-inflammatory activities. Research conducted by Huang, Z. et al. and Duan, L. et al. has demonstrated that baicalin has the ability to activate the Nrf2-HO-1 signaling pathway, reduce reactive oxygen species, and inhibit ferroptosis, resulting in a reduction of brain injury (Duan et al., 2021; Huang et al., 2021a). Baicalin has also been found to activate the PI3K/AKT signaling pathway, up-regulate glutamate transporter 1, increase the release of Brain-Derived Neurotrophic Factor (BDNF) and Tropomyosin Receptor Kinase B (TrKB), and exert antioxidant, anti-inflammatory, and neuroprotective effects during OGD/R, according to studies by Zhou et al. (2017) and Li C. et al. (2020).

4.2. Astragalus mongholicus

”Qi is the beauty of blood, and blood is the mother of qi” is a TCM theory that emphasizes the interdependence of qi and blood. To activate blood circulation, it is necessary to first promote the movement of qi. Astragalus membranaceus, known for its qi-promoting properties, can tonify qi, discharge pus, and benefit water, which indirectly helps to promote blood circulation and remove blood stasis. Its main component is astragaloside IV. Sun et al. conducted a study where they found that Astragaloside IV promoted neurogenesis and neural stem cell proliferation after stroke in a photochemical ischemia model (Sun et al., 2020). Liang, C. et al. discovered that Astragaloside IV can significantly reduce infarct size in the MACO/R model by activating the HIF/VEGF/Notch signaling pathway, increasing miRNA-210 expression, and promoting angiogenesis and cell proliferation (Liang et al., 2020). In a study by Liu et al., it was discovered that Astragaloside IV could activate the Nrf2/HO-1 signaling pathway, which in turn increased the levels of SLC7A11, GPX4, and ROS. This activation led to an enhanced antioxidant capacity and inhibition of lipid peroxidation in an ICH model with intravascular perforation (Liu Z. et al., 2022). Chen, X. et al. discovered that Astragaloside VI has the ability to target the MAPK signaling pathway that is EGF-mediated. Through activation of the EGFR/MAPK cascade, this promotes functional repair, neurogenesis, and nerve cell proliferation in MCAO models (Chen J. et al., 2019).

4.3. Rehmannia glutinosa

Rehmanniae is a form of TCM available in raw and processed forms that provides benefits such as improved blood circulation, elimination of blood stagnation, and nourishing Yin while promoting body fluids. Studies by Wang, H et al. have found that Catalpol, a compound extracted from Rehmanniae, exhibits neuroprotective properties by reducing brain damage in both in vivo MCAO/R models and in vitro OGD/R models, while also encouraging the growth, movement, and formation of blood vessels in brain microvascular endothelial cells (Wang et al., 2020). Fu, Y. et al. found that Rehmannioside A, in the MCAO/R model, can reduce cognitive dysfunction, nerve damage, and suppress ferroptosis by activating the PI3K/AKT/Nrf2 and SLC7A11/GPX4 signaling pathways (Fu et al., 2022). Astragalus membranaceus, Scutellaria baicalensis, and Rehmanniae rehmanniae are important Chinese herbs that have been used to treat cardiovascular and cerebrovascular diseases. Studies have shown that the active ingredients in these herbs have multiple therapeutic effects on stroke by targeting various pathways, including angiogenesis, inflammatory response, apoptosis, and oxidative stress. The treatment of stroke with TCM and its active components involves multiple signaling pathways, including the widely-acting PI3K/AKT and ferroptosis signaling pathways. This suggests that the treatment of stroke with TCM and its active components involves overlapping effects on multiple signaling pathways, rather than targeting a single pathway.

5. The difference and combination of traditional Chinese and Western medicine in the treatment of stroke

In the treatment of stroke, there are differences, advantages, disadvantages, and similarities between the pharmacological mechanisms of traditional Chinese medicine and Western medicine. Integrated traditional Chinese and Western medicine is becoming more common in the treatment of stroke. It is important to continue exploring the potential of traditional Chinese medicine and discovering new possibilities for combining traditional Chinese and Western medicine to provide better treatment options for stroke patients.

Western medicine utilizes drug therapy (such as intravenous thrombolysis and antiplatelets) and surgical treatments (like mechanical thrombectomy) in the treatment of stroke. These methods can help improve blood circulation and lower blood pressure, thus reducing the risk of stroke. For example, thrombolytic agents can dissolve clots, restore blood flow, and reduce the risk of ischemia. Antihypertensive drugs can lower blood pressure and reduce the risk of brain hemorrhage. However, drug therapy may also lead to adverse reactions, such as bleeding caused by thrombolytic agents (Wardlaw et al., 2014; Powers et al., 2019). Some drugs used in the treatment of stroke require long-term use, which can lead to drug resistance and dependence. In addition, surgical treatment is also an option, which can help reduce the risk of stroke by removing vascular stenosis or repairing aneurysms. For example, aneurysm surgery can prevent rupture and thus reduce the risk of intracerebral hemorrhage. However, surgical treatment may also carry surgical risks and complications, such as postoperative infection and bleeding (Powers et al., 2019; Krishnan et al., 2021). Surgical treatment may also require a longer period of rehabilitation compared to drug therapy. Additionally, Western medicine generally follows a single-target, single-pathway approach in the treatment of stroke, such as the use of intravenous thrombolytic drugs (Powers et al., 2019).

Traditional Chinese Medicine (TCM) can treat stroke through multiple targets and pathways with less risk of adverse reactions. TCM can act on various signaling pathways, such as the PI3K/AKT and SLC7A11/GPX4 pathways, which are involved in ferroptosis, angiogenesis, and neuroprotection. This multi-target approach may lead to more comprehensive and effective treatment of stroke (Fu et al., 2022). However, due to the individualized nature of TCM intervention and the lack of feasible blinding methods, it can be difficult to conduct randomized controlled trials, leading to a limited number of high-quality clinical trials for TCM in the treatment of stroke (Yang et al., 2016; Feng et al., 2022). Despite these challenges, acupuncture, a traditional Chinese medicine treatment, has gained recognition and has been shown to effectively treat stroke (Yang et al., 2016).

In the practice of integrated traditional Chinese and Western medicine for the treatment of stroke, traditional Chinese medicine, acupuncture, massage, and other TCM therapies are often combined with conventional Western medicine and surgical methods. When used in stroke rehabilitation, the combination of TCM and Western medicine has been shown to be more effective than Western medicine alone, as it can improve neurological deficits, reduce adverse reactions, and lead to better patient outcomes. This also highlights the superior efficacy of acupuncture when combined with Western medicine (Zhong L. L. et al., 2022; Hao et al., 2023). Traditional Chinese herbal medicine (TCHM) has been used as a single or adjuvant treatment for stroke, working through a variety of mechanisms such as anti-inflammation, anti-oxidative stress, anti-apoptosis, regulation of BBB, inhibition of platelet activation, and promotion of neurogenesis and angiogenesis. TCHM provides a valuable resource for the development of therapeutic drugs to treat stroke and for the discovery of more effective and safer combination therapy or individual treatment methods (Hao et al., 2023).

6. Problems and prospects

A variety of signaling pathways are associated with stroke, including angiogenesis (such as the Rho/Rock, Wnt/β-catenin, and NO signaling pathways), oxidative stress (including the Nrf2/ARE and SHH signaling pathways), immune inflammation (such as the NF-κB and TLRs signaling pathways), autophagy (including the Bnip3 signaling pathways), apoptosis (including the Notch and Hippo signaling pathways), ferroptosis, cuproptosis, and others such as the PI3K/AKT, MAPK, AMPK, and JAK/STAT signaling pathways. All of these pathways are interconnected, creating a complex network of signaling pathways involved in the pathophysiology of stroke. Stroke is a complex network disease that involves a diverse range of pathophysiological mechanisms and signaling pathways. As a result, investigating stroke requires thorough examination of various cross-talk issues.

Western medicines typically treat stroke through a single target, but due to differences in genotype and phenotype among patients, there can be poor effectiveness and significant variation in the treatment’s effects. Moreover, some drugs can cause liver damage, renal toxicity, and other side effects (O’Rourke et al., 2004). Currently, thrombolytic therapy and intravascular therapy, such asrecombinant tissue plasminogen activato (rt-PA), are still the most widely recognized treatments for stroke, often combined with auxiliary measures that have a broad range of indications (Herpich and Rincon, 2020). However, the bleeding risk to patients and the time window for thrombolysis are significant issues that cannot be ignored. Therefore, stroke centers have been established, and basic and complete pre-hospital management of stroke has been introduced in many countries (Barthels and Das, 2020). The opening of “stroke green channels” and the use of internet technology to assist with hospital admissions have also been implemented. However, these measures can be challenging to implement in developing countries, such as those in Asia and Africa, where there is limited investment and insufficient technical support. Therefore, reducing the onset symptoms of patients and extending the time window for treatment could provide significant support for the diagnosis, treatment, and prognosis of stroke (Powers et al., 2019). Due to the network nature of stroke, Western drugs that target a single pathway or target may have limitations and potential side effects.

TCM compounds or preparations and their effective ingredients have the advantage of targeting multiple pathways and targets simultaneously, including PI3K/AKT, NF-κB, and iron death pathways, and regulating various pathophysiological mechanisms such as apoptosis, oxidative stress, and inflammation in stroke (Liu et al., 2018). However, the mechanism of action of TCM remains unclear and involves effects that are multi-component, involve multiple pathways, and target multiple aspects, which is a bottleneck for the modernization and internationalization of TCM (Liu et al., 2018; Zhu et al., 2022). To overcome this, modern scientific and technological means such as network pharmacology, metabolomics, and proteomics can be used to study the effect and mechanism of TCM in stroke treatment (Kibble et al., 2015). Researchers need to clarify the signaling pathway network of stroke, identify the active ingredients in TCM, and strengthen pharmacodynamic and pharmacokinetic studies to clarify their pharmacological and toxic effects. Compound Chinese medicines have shown neuroprotective and damage-reducing effects on stroke in animal experiments, but their regional promotion is limited to clinical trials in China. Therefore, it is crucial to develop these compound Chinese medicines and promote them globally (Liu et al., 2018; Lou et al., 2022). TCM has shown to have fewer side effects and can be widely promoted in developing countries, especially in Asia and Africa, for the prevention and treatment of stroke. Moreover, TCM can also be used to assist the diagnosis, treatment, and recovery of stroke in developed countries (Sarfo et al., 2023). It is crucial to develop TCM suitable for stroke treatment, as it can be used as a means to extend the time window of stroke, retard the advancement of the ailment, and improve the prognosis and rehabilitation (Liu et al., 2018; Zhu et al., 2022). Therefore, the multi-target and multi-pathway treatment approach of TCM aligns with the complex network nature of stroke as a disease.

Network pharmacology has emerged for drug target discovery, experimental design, mechanism study, and efficacy evaluation in the exploration of TCM treatment strategies for stroke (Kibble et al., 2015; Zheng et al., 2022). It is a necessary, conditional, directional, and innovative approach. However, while network pharmacology is a hot topic, the credibility and professionalism of the network pharmacology databases need to be improved, and some network pharmacology articles remain limited to data mining. Although network pharmacology combined with experimental verification is reliable for TCM treatment of stroke, research on TCM in stroke models is still limited to preliminary experimental research and lacks clinical translation (Zheng et al., 2022).

In summary, stroke is a complex disease involved with numerous signal pathways, which makes it difficult to treat. Some western drugs like tissue plasminase (tPA) and aspirin have been used clinically, they have limited effects and side effects. TCM possesses significant potential in the treatment of stroke and is a valuable resource in this regard. However, stroke treatment research has been mostly limited to animal experiments and lacks clinical transformation (Liu et al., 2018; Powers et al., 2019; Zhu et al., 2022). It is essential to explore the potential therapy of integrated traditional Chinese and western medicine in the treatment of stroke. By combining the advantages of both approaches, this therapy can complement each other’s shortcomings, add high-quality evidence, reduce adverse reactions, and increase drug efficacy. TCM is a vast treasure trove, and there are many potential drugs that can be developed from it. Therefore, in the future, efforts should be directed towards excavating and developing the TCM treasure trove (Duan T. et al., 2022; Feng et al., 2022; Zhong L. L. et al., 2022; Hao et al., 2023). Additionally, it is essential to focus on the development of TCM placebo and randomized controlled trials to improve the credibility of TCM for stroke treatment. Network pharmacology and metabolomics can be used to mine data and conduct theoretical research in combination with Chinese traditional medical codes to find strong evidence to support the potential therapeutic effect of TCM. It is crucial to carry out clinical practice of TCM and its effective ingredients and to discover the possibility of treating stroke with integrated Chinese and western medicine. Multi-mode treatment of stroke can be explored to improve the possible direction of stroke treatment (Yang et al., 2016; Liu et al., 2018; Duan T. et al., 2022; Zhu et al., 2022). In conclusion, we propose embracing a network disease perspective when considering stroke, as it highlights the significance of acknowledging the multifaceted nature of stroke, including its multiple targets, pathways, and channels. By adopting this approach, we can facilitate the development of novel therapeutic strategies to effectively treat stroke.

References

• 1

  Abdel-Latif R. G. Rifaai R. A. Amin E. F. (2020). Empagliflozin alleviates neuronal apoptosis induced by cerebral ischemia/reperfusion injury through HIF-1α/VEGF signaling pathway.Arch. Pharm. Res.43514–525. 10.1007/s12272-020-01237-y

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 2

  Agashe R. P. Lippman S. M. Kurzrock R. (2022). JAK: Not just another kinase.Mol. Cancer Ther.211757–1764. 10.1158/1535-7163.MCT-22-0323

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 3

  Ahmed S. M. Luo L. Namani A. Wang X. J. Tang X. (2017). Nrf2 signaling pathway: Pivotal roles in inflammation.Biochim. Biophys. Acta Mol. Basis Dis.1863585–597. 10.1016/j.bbadis.2016.11.005

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 4

  Aktories K. Weller U. Chhatwal G. S. (1987). Clostridium botulinum type C produces a novel ADP-ribosyltransferase distinct from botulinum C2 toxin.FEBS Lett.212109–113. 10.1016/0014-5793(87)81566-1

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 5

  Alam J. Stewart D. Touchard C. Boinapally S. Choi A. M. Cook J. L. (1999). Nrf2, a Cap’n’Collar transcription factor, regulates induction of the heme oxygenase-1 gene.J. Biol. Chem.27426071–26078.

  • Google Scholar

• 6

  Albéri L. Chi Z. Kadam S. D. Mulholland J. D. Dawson V. L. Gaiano N. et al (2010). Neonatal stroke in mice causes long-term changes in neuronal Notch-2 expression that may contribute to prolonged injury.Stroke41S64–S71. 10.1161/STROKEAHA.110.595298

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 7

  Alfieri A. Srivastava S. Siow R. C. M. Cash D. Modo M. Duchen M. R. et al (2013). Sulforaphane preconditioning of the Nrf2/HO-1 defense pathway protects the cerebral vasculature against blood-brain barrier disruption and neurological deficits in stroke.Free Radic. Biol. Med.651012–1022. 10.1016/j.freeradbiomed.2013.08.190

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 8

  Alfieri A. Srivastava S. Siow R. C. Modo M. Fraser P. A. Mann G. E. (2011). Targeting the Nrf2-Keap1 antioxidant defence pathway for neurovascular protection in stroke.J. Physiol.5894125–4136. 10.1113/jphysiol.2011.210294

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 9

  Ali C. Docagne F. Nicole O. LESNé S. Toutain J. Young A. et al (2001). Increased expression of transforming growth factor-beta after cerebral ischemia in the baboon: An endogenous marker of neuronal stress?J. Cereb. Blood Flow Metab.21820–827. 10.1097/00004647-200107000-00007

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 10

  Alim I. Caulfield J. T. Chen Y. Swarup V. Geschwind D. H. Ivanova E. et al (2019). Selenium drives a transcriptional adaptive program to block ferroptosis and treat stroke.Cell1771262–1279.e25. 10.1016/j.cell.2019.03.032

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 11

  Allen C. L. Bayraktutan U. (2009). Oxidative stress and its role in the pathogenesis of ischaemic stroke.Int. J. Stroke4461–470.

  • Google Scholar

• 12

  Amerongen V. N. Koolwijk P. Versteilen A. Van H. (2003). Involvement of RhoA/Rho kinase signaling in VEGF-induced endothelial cell migration and angiogenesis in vitro.Arterioscler. Thromb. Vasc. Biol.23211–217. 10.1161/01.atv.0000054198.68894.88

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 13

  Anderson K. V. Jürgens G. Nüsslein-Volhard C. (1985). Establishment of dorsal-ventral polarity in the Drosophila embryo: Genetic studies on the role of the Toll gene product.Cell42779–789.

  • Google Scholar

• 14

  Andersson E. R. Lendahl U. (2014). Therapeutic modulation of Notch signalling–are we there yet?Nat. Rev. Drug Discov.13357–378. 10.1038/nrd4252

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 15

  Andersson E. R. Sandberg R. Lendahl U. (2011). Notch signaling: Simplicity in design, versatility in function.Development1383593–3612. 10.1242/dev.063610

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 16

  Arnold R. Vehns E. Randl H. Djabali K. (2021). Baricitinib, a JAK-STAT inhibitor, reduces the cellular toxicity of the farnesyltransferase inhibitor lonafarnib in progeria cells.Int. J. Mol. Sci.22:7474. 10.3390/ijms22147474

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 17

  Artavanis-Tsakonas S. Muskavitch M. A. Yedvobnick B. (1983). Molecular cloning of Notch, a locus affecting neurogenesis in Drosophila melanogaster.Proc. Natl. Acad. Sci. U. S. A.801977–1981. 10.1073/pnas.80.7.1977

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 18

  Arumugam T. V. Chan S. L. Jo D. G. Yilmaz G. Tang S. C. Cheng A. et al (2006). Gamma secretase-mediated notch signaling worsens brain damage and functional outcome in ischemic stroke.Nat. Med.12621–623. 10.1038/nm1403

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 19

  Arvin B. Neville L. F. Barone F. C. Feuerstein G. Z. (1996). The role of inflammation and cytokines in brain injury.Neurosci. Biobehav. Rev.20445–452.

  • Google Scholar

• 20

  Attisano L. Wrana J. L. (2002). Signal transduction by the TGF-beta superfamily.Science2961646–1647.

  • Google Scholar

• 21

  Austin J. Kimble J. (1989). Transcript analysis of glp-1 and lin-12, homologous genes required for cell interactions during development of C. elegans.Cell58565–571. 10.1016/0092-8674(89)90437-6

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 22

  Aylon Y. Oren M. (2007). Living with p53, dying of p53.Cell130597–600. 10.1016/j.cell.2007.08.005

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 23

  Azzolin L. Panciera T. Soligo S. Enzo E. Bicciato S. Dupont S. et al (2014). YAP/TAZ incorporation in the β-catenin destruction complex orchestrates the Wnt response.Cell158157–170. 10.1016/j.cell.2014.06.013

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 24

  Azzolin L. Zanconato F. Bresolin S. Forcato M. Basso G. Bicciato S. et al (2012). Role of TAZ as mediator of Wnt signaling.Cell1511443–1456. 10.1016/j.cell.2012.11.027

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 25

  Bannai S. Kitamura E. (1980). Transport interaction of L-cystine and L-glutamate in human diploid fibroblasts in culture.J. Biol. Chem.2552372–2376. 10.1016/S0021-9258(19)85901-X

  • CrossRef
  • Google Scholar

• 26

  Barabási A. L. Gulbahce N. Loscalzo J. (2011). Network medicine: A network-based approach to human disease.Nat. Rev. Genet.1256–68. 10.1038/nrg2918

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 27

  Barone F. C. Feuerstein G. Z. (1999). Inflammatory mediators and stroke: New opportunities for novel therapeutics.J. Cereb. Blood Flow Metab.19819–834. 10.1097/00004647-199908000-00001

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 28

  Barone F. C. Irving E. A. Ray A. M. Lee J. C. Kassis S. Kumar S. et al (2001). Inhibition of p38 mitogen-activated protein kinase provides neuroprotection in cerebral focal ischemia.Med. Res. Rev.21129–145.

  • Google Scholar

• 29

  Barrat F. J. Crow M. K. Ivashkiv L. B. (2019). Interferon target-gene expression and epigenomic signatures in health and disease.Nat. Immunol.201574–1583. 10.1038/s41590-019-0466-2

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 30

  Barthels D. Das H. (2020). Current advances in ischemic stroke research and therapies.Biochim. Biophys. Acta Mol. Basis Dis.1866:165260. 10.1016/j.bbadis.2018.09.012

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 31

  Bartlett J. D. Close G. L. Drust B. Morton J. P. (2014). The emerging role of p53 in exercise metabolism.Sports Med.44303–309. 10.1007/s40279-013-0127-9

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 32

  Bermudez O. PAGèS G. Gimond C. (2010). The dual-specificity MAP kinase phosphatases: Critical roles in development and cancer.Am. J. Physiol. Cell Physiol.299C189–C202. 10.1152/ajpcell.00347.2009

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 33

  Bhanot P. Brink M. Samos C. H. Hsieh J. C. Wang Y. Macke J. P. et al (1996). A new member of the frizzled family from Drosophila functions as a wingless receptor.Nature382225–230. 10.1038/382225a0

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 34

  Boulton T. G. Yancopoulos G. D. Gregory J. S. Slaughter C. Moomaw C. Hsu J. et al (1990). An insulin-stimulated protein kinase similar to yeast kinases involved in cell cycle control.Science24964–67. 10.1126/science.2164259

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 35

  Boutros T. Chevet E. Metrakos P. (2008). Mitogen-activated protein (MAP) kinase/MAP kinase phosphatase regulation: Roles in cell growth, death, and cancer.Pharmacol. Rev.60261–310.

  • Google Scholar

• 36

  Boyd J. M. Malstrom S. Subramanian T. Venkatesh L. K. Schaeper U. Elangovan B. et al (1994). Adenovirus E1B 19 kDa and Bcl-2 proteins interact with a common set of cellular proteins.Cell79341–351. 10.1016/0092-8674(94)90202-X

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 37

  Brand K. Page S. Rogler G. Bartsch A. Brandl R. Knuechel R. et al (1996). Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion.J. Clin. Invest.971715–1722. 10.1172/JCI118598

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 38

  Bredesen D. E. (1995). Neural apoptosis.Ann. Neurol.38839–851. 10.1002/ana.410380604

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 39

  Bridges C. B. (1916). Non-disjunction as proof of the chromosome theory of heredity (concluded).Genetics1107–163. 10.1093/genetics/1.2.107

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 40

  Bruggen V. Thibodeaux H. Palmer J. T. Lee W. P. Fu L. Cairns B. et al (1999). VEGF antagonism reduces edema formation and tissue damage after ischemia/reperfusion injury in the mouse brain.J. Clin. Invest.1041613–1620. 10.1172/JCI8218

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 41

  Burgering B. M. Coffer P. J. (1995). Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction.Nature376599–602.

  • Google Scholar

• 42

  Burton T. R. Gibson S. B. (2009). The role of Bcl-2 family member BNIP3 in cell death and disease: NIPping at the heels of cell death.Cell Death Differ.16515–523. 10.1038/cdd.2008.185

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 43

  Campos A. H. Wang W. Pollman M. J. Gibbons G. H. (2002). Determinants of Notch-3 receptor expression and signaling in vascular smooth muscle cells: Implications in cell-cycle regulation.Circ. Res.91999–1006. 10.1161/01.res.0000044944.99984.25

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 44

  Cano E. Mahadevan L. C. (1995). Parallel signal processing among mammalian MAPKs.Trends Biochem. Sci.20117–122. 10.1016/s0968-0004(00)88978-1

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 45

  Cantley L. C. (2002). The phosphoinositide 3-kinase pathway.Science2961655–1657.

  • Google Scholar

• 46

  Carling D. Zammit V. A. Hardie D. G. (1987). A common bicyclic protein kinase cascade inactivates the regulatory enzymes of fatty acid and cholesterol biosynthesis.FEBS Lett.223217–222. 10.1016/0014-5793(87)80292-2

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 47

  Carmeliet P. Dor Y. Herbert J. M. Fukumura D. Brusselmans K. Dewerchin M. et al (1998). Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis.Nature394485–490. 10.1038/28867

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 48

  Carriere V. Roussel L. Ortega N. Lacorre D. A. Americh L. Aguilar L. et al (2007). IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo.Proc. Natl. Acad. Sci. U. S. A.104282–287.

  • Google Scholar

• 49

  Chan J. Y. Kwong M. Lu R. Chang J. Wang B. Yen T. S. et al (1998). Targeted disruption of the ubiquitous CNC-bZIP transcription factor, Nrf-1, results in anemia and embryonic lethality in mice.Embo J.171779–1787. 10.1093/emboj/17.6.1779

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 50

  Chan P. H. (2005). Mitochondrial dysfunction and oxidative stress as determinants of cell death/survival in stroke.Ann. N. Y. Acad. Sci.1042203–209.

  • Google Scholar

• 51

  Chang H. Lin C. Li Z. Shen Y. Zhang G. Mao L. et al (2022). T3 alleviates neuroinflammation and reduces early brain injury after subarachnoid haemorrhage by promoting mitophagy via PINK 1-parkin pathway.Exp. Neurol.357:114175. 10.1016/j.expneurol.2022.114175

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 52

  Chang T. S. Jensen M. B. (2014). Haemodilution for acute ischaemic stroke.Cochrane Database Syst. Rev.2014:Cd000103.

  • Google Scholar

• 53

  Chen B. Cao P. Guo X. Yin M. Li X. Jiang L. et al (2022). Maraviroc, an inhibitor of chemokine receptor type 5, alleviates neuroinflammatory response after cerebral Ischemia/reperfusion injury via regulating MAPK/NF-κB signaling.Int. Immunopharmacol.108:108755.

  • Google Scholar

• 54

  Chen G. Ray R. Dubik D. Shi L. Cizeau J. Bleackley R. C. et al (1997). The E1B 19K/Bcl-2-binding protein Nip3 is a dimeric mitochondrial protein that activates apoptosis.J. Exp. Med.1861975–1983. 10.1084/jem.186.12.1975

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 55

  Chen J. Lin X. Yao C. Bingwa L. A. Wang H. Lin Z. et al (2022). Transplantation of Roxadustat-preconditioned bone marrow stromal cells improves neurological function recovery through enhancing grafted cell survival in ischemic stroke rats.CNS Neurosci. Ther.281519–1531. 10.1111/cns.13890

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 56

  Chen J. Zacharek A. Li A. Cui X. Roberts C. Lu M. et al (2008). Atorvastatin promotes presenilin-1 expression and Notch1 activity and increases neural progenitor cell proliferation after stroke.Stroke39220–226. 10.1161/STROKEAHA.107.490946

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 57

  Chen J. Zhang X. Liu X. Zhang C. Shang W. Xue J. et al (2019). Ginsenoside Rg1 promotes cerebral angiogenesis via the PI3K/Akt/mTOR signaling pathway in ischemic mice.Eur. J. Pharmacol.856:172418. 10.1016/j.ejphar.2019.172418

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 58

  Chen L. Min J. Wang F. (2022). Copper homeostasis and cuproptosis in health and disease.Signal. Transduct. Target Ther.7:378. 10.1038/s41392-022-01229-y

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 59

  Chen R. L. Ogunshola O. O. Yeoh K. K. Jani A. Papadakis M. Nagel S. et al (2014). HIF prolyl hydroxylase inhibition prior to transient focal cerebral ischaemia is neuroprotective in mice.J. Neurochem.131177–189. 10.1111/jnc.12804

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 60

  Chen S. Peng J. Sherchan P. Ma Y. Xiang S. Yan F. et al (2020). TREM2 activation attenuates neuroinflammation and neuronal apoptosis via PI3K/Akt pathway after intracerebral hemorrhage in mice.J. Neuroinflammation17:168. 10.1186/s12974-020-01853-x

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 61

  Chen S. Zhang J. Li M. Zhou J. Zhang Y. (2022). Danhong injection combined with tPA protects the BBB through Notch-VEGF signaling pathway on long-term outcomes of thrombolytic therapy.Biomed. Pharmacother.153:113288. 10.1016/j.biopha.2022.113288

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 62

  Chen X. Kang R. Kroemer G. Tang D. (2021a). Broadening horizons: The role of ferroptosis in cancer.Nat. Rev. Clin. Oncol.18280–296. 10.1038/s41571-020-00462-0

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 63

  Chen X. Kang R. Kroemer G. Tang D. (2021b). Ferroptosis in infection, inflammation, and immunity.J. Exp. Med.218:e20210518.

  • Google Scholar

• 64

  Chen X. Wu H. Chen H. Wang Q. Xie X. J. Shen J. (2019). Astragaloside VI promotes neural stem cell proliferation and enhances neurological function recovery in transient cerebral ischemic injury via activating EGFR/MAPK signaling cascades.Mol. Neurobiol.563053–3067. 10.1007/s12035-018-1294-3

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 65

  Cheng Y. L. Park J. S. Manzanero S. Choi Y. Baik S. H. Okun E. et al (2014). Evidence that collaboration between HIF-1α and Notch-1 promotes neuronal cell death in ischemic stroke.Neurobiol. Dis.62286–295.

  • Google Scholar

• 66

  Chien M. Y. Chuang C. H. Chern C. M. Liou K. T. Liu D. Z. Hou Y. C. et al (2016). Salvianolic acid A alleviates ischemic brain injury through the inhibition of inflammation and apoptosis and the promotion of neurogenesis in mice.Free Radic. Biol. Med.99508–519. 10.1016/j.freeradbiomed.2016.09.006

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 67

  Chinnadurai G. Vijayalingam S. Gibson S. B. (2008). BNIP3 subfamily BH3-only proteins: Mitochondrial stress sensors in normal and pathological functions.Oncogene27S114–S127. 10.1038/onc.2009.49

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 68

  Chio I. I. C. Jafarnejad S. M. Ponz-Sarvise M. Park Y. Rivera K. Palm W. et al (2016). NRF2 promotes tumor maintenance by modulating mRNA translation in pancreatic cancer.Cell166963–976. 10.1016/j.cell.2016.06.056

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 69

  Chou W. C. Rampanelli E. Li X. Ting J. P. (2022). Impact of intracellular innate immune receptors on immunometabolism.Cell Mol. Immunol.19337–351.

  • Google Scholar

• 70

  Cinelli M. A. Do H. T. Miley G. P. Silverman R. B. (2020). Inducible nitric oxide synthase: Regulation, structure, and inhibition.Med. Res. Rev.40158–189.

  • Google Scholar

• 71

  Clark I. E. Dodson M. W. Jiang C. Cao J. H. Huh J. R. Seol J. H. et al (2006). Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin.Nature4411162–1166.

  • Google Scholar

• 72

  Cochrane A. Chen C. Stephen J. RøNNING O. M. Anderson C. S. Hankey G. J. et al (2023). Antithrombotic treatment after stroke due to intracerebral haemorrhage.Cochrane Database Syst. Rev.1:Cd012144.

  • Google Scholar

• 73

  Coffman C. Harris W. Kintner C. (1990). Xotch, the xenopus homolog of drosophila notch.Science2491438–1441.

  • Google Scholar

• 74

  Collino M. Aragno M. Mastrocola R. Benetti E. Gallicchio M. Dianzani C. et al (2006). Oxidative stress and inflammatory response evoked by transient cerebral ischemia/reperfusion: Effects of the PPAR-alpha agonist WY14643.Free Radic. Biol. Med.41579–589. 10.1016/j.freeradbiomed.2006.04.030

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 75

  Cook D. N. Pisetsky D. S. Schwartz D. A. (2004). Toll-like receptors in the pathogenesis of human disease.Nat. Immunol.5975–979.

  • Google Scholar

• 76

  Cooper J. A. Bowen-Pope D. F. Raines E. Ross R. Hunter T. (1982). Similar effects of platelet-derived growth factor and epidermal growth factor on the phosphorylation of tyrosine in cellular proteins.Cell31263–273.

  • Google Scholar

• 77

  Cooperative Group for Reassessment of Defibrase (2005). Reassessment of defibrase in treatment of acute cerebral infarction: A multicenter, randomized, double-blind, placebo-controlled trial.Chin. Med. Sci. J.20151–158.

  • Pubmed Abstract
  • Google Scholar

• 78

  Couzin-Frankel J. (2013). Breakthrough of the year 2013.Cancer Immunother. Sci.3421432–1433.

  • Google Scholar

• 79

  Coyle J. T. Puttfarcken P. (1993). Oxidative stress, glutamate, and neurodegenerative disorders.Science262689–695.

  • Google Scholar

• 80

  Croll S. D. Wiegand S. J. (2001). Vascular growth factors in cerebral ischemia.Mol. Neurobiol.23121–135.

  • Google Scholar

• 81

  Cui H. Y. Zhang X. J. Yang Y. Zhang C. Zhu C. H. Miao J. Y. et al (2018). Rosmarinic acid elicits neuroprotection in ischemic stroke via Nrf2 and heme oxygenase 1 signaling.Neural Regen. Res.132119–2128. 10.4103/1673-5374.241463

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 82

  Cui Y. Zhang Y. Zhao X. Shao L. Liu G. Sun C. et al (2021). ACSL4 exacerbates ischemic stroke by promoting ferroptosis-induced brain injury and neuroinflammation.Brain Behav. Immun.93312–321. 10.1016/j.bbi.2021.01.003

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 83

  Culman J. Zhao Y. Gohlke P. Herdegen T. (2007). PPAR-gamma: Therapeutic target for ischemic stroke.Trends Pharmacol. Sci.28244–249.

  • Google Scholar

• 84

  Darnell J. E. Jr. Kerr I. M. Stark G. R. (1994). Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins.Science2641415–1421. 10.1126/science.8197455

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 85

  D’Autréaux B. Toledano M. B. (2007). ROS as signalling molecules: Mechanisms that generate specificity in ROS homeostasis.Nat. Rev. Mol. Cell Biol.8813–824. 10.1038/nrm2256

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 86

  Dávalos A. Secades J. (2011). Citicoline preclinical and clinical update 2009-2010.Stroke42S36–S39. 10.1161/STROKEAHA.110.605568

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 87

  Davalos D. Grutzendler J. Yang G. Kim J. V. Zuo Y. Jung S. et al (2005). ATP mediates rapid microglial response to local brain injury in vivo.Nat. Neurosci.8752–758. 10.1038/nn1472

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 88

  Dave K. D. De S. Sheth N. P. Ramboz S. Beck M. J. Quang C. et al (2014). Phenotypic characterization of recessive gene knockout rat models of Parkinson’s disease.Neurobiol. Dis.70190–203. 10.1016/j.nbd.2014.06.009

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 89

  Davis R. J. (1994). MAPKs: New JNK expands the group.Trends Biochem. Sci.19470–473. 10.1016/0968-0004(94)90132-5

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 90

  Deleo A. B. Jay G. Appella E. Dubois G. C. Law L. W. Old L. J. (1979). Detection of a transformation-related antigen in chemically induced sarcomas and other transformed cells of the mouse.Proc. Natl. Acad. Sci. U. S. A.762420–2424.

  • Google Scholar

• 91

  Dey A. Varelas X. Guan K. L. (2020). Targeting the Hippo pathway in cancer, fibrosis, wound healing and regenerative medicine.Nat. Rev. Drug Discov.19480–494. 10.1038/s41573-020-0070-z

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 92

  Didonato J. A. Mercurio F. Karin M. (2012). NF-κB and the link between inflammation and cancer.Immunol. Rev.246379–400.

  • Google Scholar

• 93

  Ding J. Y. Pan L. Q. Hu Y. Y. Rajah G. B. Zhou D. Bai C. B. et al (2019). Batroxobin in combination with anticoagulation may promote venous sinus recanalization in cerebral venous thrombosis: A real-world experience.CNS Neurosci. Ther.25638–646. 10.1111/cns.13093

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 94

  Ding Y. Chen M. Wang M. Li Y. Wen A. (2015). Posttreatment with 11-Keto-β-boswellic acid ameliorates cerebral ischemia-reperfusion injury: Nrf2/HO-1 pathway as a potential mechanism.Mol. Neurobiol.521430–1439.

  • Google Scholar

• 95

  Ding Y. Qian J. Li H. Shen H. Li X. Kong Y. et al (2019). Effects of SC99 on cerebral ischemia-perfusion injury in rats: Selective modulation of microglia polarization to M2 phenotype via inhibiting JAK2-STAT3 pathway.Neurosci. Res.14258–68. 10.1016/j.neures.2018.05.002

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 96

  Dirnagl U. Iadecola C. Moskowitz M. A. (1999). Pathobiology of ischaemic stroke: An integrated view.Trends Neurosci.22391–397. 10.1016/s0166-2236(99)01401-0

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 97

  Dixon S. J. Lemberg K. M. Lamprecht M. R. Skouta R. Zaitsev E. M. Gleason C. E. et al (2012). Ferroptosis: An iron-dependent form of nonapoptotic cell death.Cell1491060–1072.

  • Google Scholar

• 98

  Doll S. Freitas F. P. Shah R. Aldrovandi M. Da S. Ingold I. et al (2019). FSP1 is a glutathione-independent ferroptosis suppressor.Nature575693–698.

  • Google Scholar

• 99

  Doll S. Proneth B. Tyurina Y. Y. Panzilius E. Kobayashi S. Ingold I. et al (2017). ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition.Nat. Chem. Biol.1391–98. 10.1038/nchembio.2239

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 100

  Dolma S. Lessnick S. L. Hahn W. C. Stockwell B. R. (2003). Identification of genotype-selective antitumor agents using synthetic lethal chemical screening in engineered human tumor cells.Cancer Cell3285–296. 10.1016/s1535-6108(03)00050-3

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 101

  Dong W. Xian Y. Yuan W. Huifeng Z. Tao W. Zhiqiang L. et al (2016). Catalpol stimulates VEGF production via the JAK2/STAT3 pathway to improve angiogenesis in rats’ stroke model.J. Ethnopharmacol.191169–179. 10.1016/j.jep.2016.06.030

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 102

  Donnan G. A. Fisher M. Macleod M. Davis S. M. (2008). Stroke.Lancet3711612–1623.

  • Google Scholar

• 103

  Duan C. Wang H. Jiao D. Geng Y. Wu Q. Yan H. et al (2022). Curcumin restrains oxidative stress of after intracerebral hemorrhage in rat by activating the Nrf2/HO-1 Pathway.Front. Pharmacol.13:889226. 10.3389/fphar.2022.889226

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 104

  Duan J. Cui J. Yang Z. Guo C. Cao J. Xi M. et al (2019). Neuroprotective effect of Apelin 13 on ischemic stroke by activating AMPK/GSK-3β/Nrf2 signaling.J. Neuroinflammation1624.

  • Google Scholar

• 105

  Duan L. Zhang Y. Yang Y. Su S. Zhou L. Lo P. C. et al (2021). Baicalin inhibits ferroptosis in intracerebral hemorrhage.Front. Pharmacol.12:629379. 10.3389/fphar.2021.629379

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 106

  Duan T. Li L. Yu Y. Li T. Han R. Sun X. et al (2022). Traditional Chinese medicine use in the pathophysiological processes of intracerebral hemorrhage and comparison with conventional therapy.Pharmacol. Res.179:106200. 10.1016/j.phrs.2022.106200

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 107

  Durrant T. N. Hers I. (2020). PI3K inhibitors in thrombosis and cardiovascular disease.Clin. Transl. Med.9:8.

  • Google Scholar

• 108

  Echelard Y. Epstein D. J. St-Jacques B. Shen L. Mohler J. Mcmahon J. A. et al (1993). Sonic hedgehog, a member of a family of putative signaling molecules, is implicated in the regulation of CNS polarity.Cell751417–1430. 10.1016/0092-8674(93)90627-3

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 109

  Elbediwy A. Vincent-Mistiaen Z. I. Spencer-Dene B. Stone R. K. Boeing S. Wculek S. K. et al (2016). Integrin signalling regulates YAP and TAZ to control skin homeostasis.Development1431674–1687. 10.1242/dev.133728

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 110

  Endres M. Laufs U. Liao J. K. Moskowitz M. A. (2004). Targeting eNOS for stroke protection.Trends Neurosci.27283–289.

  • Google Scholar

• 111

  Erlich S. Shohami E. Pinkas-Kramarski R. (2000). Closed head injury induces up-regulation of ErbB-4 receptor at the site of injury.Mol. Cell Neurosci.16597–608. 10.1006/mcne.2000.0894

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 112

  Fann D. Y. Lim Y. A. Cheng Y. L. Lok K. Z. Chunduri P. Baik S. H. et al (2018). Evidence that NF-κB and MAPK Signaling Promotes NLRP Inflammasome Activation in Neurons Following Ischemic Stroke.Mol. Neurobiol.551082–1096.

  • Google Scholar

• 113

  Fedorowicz M. A. De V. RüB C. Becker D. Huang Y. Zhou C. et al (2014). Cytosolic cleaved PINK1 represses Parkin translocation to mitochondria and mitophagy.Embo Rep.1586–93. 10.1002/embr.201337294

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 114

  Feng C. N. Ji Z. C. Peng D. H. Hu H. Y. Zhang J. H. Pang B. (2022). [Clinical trials and evaluation of Chinese patent medicine for stroke].Zhongguo Zhong Yao Za Zhi472330–2337.

  • Google Scholar

• 115

  Feng S. Yang Q. Liu M. Li W. Yuan W. Zhang S. et al (2011). Edaravone for acute ischaemic stroke. Cochrane Database Syst. Rev. 7:CD007230. 10.1002/14651858.CD007230.pub2

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 116

  Fernandez L. A. Northcott P. A. Dalton J. Fraga C. Ellison D. Angers S. et al (2009). YAP1 is amplified and up-regulated in hedgehog-associated medulloblastomas and mediates Sonic hedgehog-driven neural precursor proliferation.Genes Dev.232729–2741. 10.1101/gad.1824509

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 117

  Ferrara N. (2001). Role of vascular endothelial growth factor in regulation of physiological angiogenesis.Am. J. Physiol. Cell Physiol.280C1358–C1366.

  • Google Scholar

• 118

  Ferrara N. Henzel W. J. (1989). Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells.Biochem. Biophys. Res. Commun.161851–858.

  • Google Scholar

• 119

  Fong W. H. Tsai H. D. Chen Y. C. Wu J. S. Lin T. N. (2010). Anti-apoptotic actions of PPAR-gamma against ischemic stroke.Mol. Neurobiol.41180–186. 10.1007/s12035-010-8103-y

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 120

  Foster-Goldman A. Mccarthy D. (2013). Angioedema from recombinant TPA administration: Case report and pathophysiology review.Am. J. Ther.20691–693. 10.1097/MJT.0b013e3182799083

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 121

  Frame S. Cohen P. (2001). GSK3 takes centre stage more than 20 years after its discovery.Biochem. J.3591–16. 10.1042/0264-6021:3590001

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 122

  Franke T. F. Yang S. I. Chan T. O. Datta K. Kazlauskas A. Morrison D. K. et al (1995). The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase.Cell81727–736. 10.1016/0092-8674(95)90534-0

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 123

  Fresno V. J. Casado E. de Castro J. Cejas P. Belda-Iniesta C. González-Barón M. (2004). PI3K/Akt signalling pathway and cancer.Cancer Treat Rev.30193–204.

  • Google Scholar

• 124

  Fu A. Eberhard C. E. Screaton R. A. (2013). Role of AMPK in pancreatic beta cell function.Mol. Cell Endocrinol.366127–134.

  • Google Scholar

• 125

  Fu C. Wu Y. Liu S. Luo C. Lu Y. Liu M. et al (2022). Rehmannioside a improves cognitive impairment and alleviates ferroptosis via activating PI3K/AKT/Nrf2 and SLC7A11/GPX4 signaling pathway after ischemia.J. Ethnopharmacol.289:115021. 10.1016/j.jep.2022.115021

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 126

  Furchgott R. F. Zawadzki J. V. (1980). The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine.Nature288373–376.

  • Google Scholar

• 127

  Furlan A. Higashida R. Wechsler L. Gent M. Rowley H. Kase C. et al (1999). Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: A randomized controlled trial. Prolyse in acute cerebral thromboembolism.JAMA2822003–2011.

  • Google Scholar

• 128

  GBD 2019 Stroke Collaborators (2021). Global, regional, and national burden of stroke and its risk factors, 1990-2019: A systematic analysis for the global burden of disease study 2019.Lancet Neurol.20795–820.

  • Google Scholar

• 129

  Geisler S. HOLMSTRöM K. M. Skujat D. Fiesel F. C. Rothfuss O. C. Kahle P. J. et al (2010). PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1.Nat. Cell Biol.12119–131. 10.1038/ncb2012

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 130

  Ghigo A. Laffargue M. Li M. Hirsch E. (2017). PI3K and calcium signaling in cardiovascular disease.Circ. Res.121282–292. 10.1161/CIRCRESAHA.117.310183

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 131

  Gold R. Kappos L. Arnold D. L. Bar-Or A. Giovannoni G. Selmaj K. et al (2012). Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis.N. Engl. J. Med.3671098–1107. 10.1056/NEJMoa1114287

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 132

  Gong P. Zhang Z. Zou C. Tian Q. Chen X. Hong M. et al (2019). Hippo/YAP signaling pathway mitigates blood-brain barrier disruption after cerebral ischemia/reperfusion injury.Behav. Brain Res.3568–17. 10.1016/j.bbr.2018.08.003

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 133

  Gong S. Ma H. Zheng F. Huang J. Zhang Y. Yu B. et al (2021). Inhibiting YAP in endothelial cells from entering the nucleus attenuates blood-brain barrier damage during ischemia-reperfusion injury.Front. Pharmacol.12:777680. 10.3389/fphar.2021.777680

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 134

  Gough N. R. Xiang X. Mishra L. (2021). TGF-β signaling in liver, pancreas, and gastrointestinal diseases and cancer.Gastroenterology161434–452.e15. 10.1053/j.gastro.2021.04.064

  • CrossRef
  • Google Scholar

• 135

  Gracey E. Hromadová D. Lim M. Qaiyum Z. Zeng M. Yao Y. et al (2020). TYK2 inhibition reduces type 3 immunity and modifies disease progression in murine spondyloarthritis.J. Clin. Invest.1301863–1878. 10.1172/JCI126567

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 136

  Greenlund A. C. Farrar M. A. Viviano B. L. Schreiber R. D. (1994). Ligand-induced IFN gamma receptor tyrosine phosphorylation couples the receptor to its signal transduction system (p91).Embo J.131591–1600. 10.1002/j.1460-2075.1994.tb06422.x

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 137

  Greer D. M. (2010). Aspirin and antiplatelet agent resistance: Implications for prevention of secondary stroke.CNS Drugs241027–1040. 10.2165/11539160-0000000000-00000

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 138

  Greten F. R. Eckmann L. Greten T. F. Park J. M. Li Z. W. Egan L. J. et al (2004). IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer.Cell118285–296. 10.1016/j.cell.2004.07.013

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 139

  Griffith T. M. Edwards D. H. Lewis M. J. Newby A. C. Henderson A. H. (1984). The nature of endothelium-derived vascular relaxant factor.Nature308645–647. 10.1038/308645a0

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 140

  Grijalva J. L. Huizenga M. Mueller K. Rodriguez S. Brazzo J. Camargo F. et al (2014). Dynamic alterations in Hippo signaling pathway and YAP activation during liver regeneration.Am. J. Physiol. Gastrointest. Liver Physiol.307G196–G204. 10.1152/ajpgi.00077.2014

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 141

  Gross S. S. Wolin M. S. (1995). Nitric oxide: Pathophysiological mechanisms.Annu. Rev. Physiol.57737–769. 10.1146/annurev.ph.57.030195.003513

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 142

  Guo H. Zhang W. Wang Z. Li Z. Zhou J. Yang Z. (2022). Dexmedetomidine post-conditioning protects blood-brain barrier integrity by modulating microglia/macrophage polarization via inhibiting NF-κB signaling pathway in intracerebral hemorrhage.Front. Mol. Neurosci.15:977941. 10.3389/fnmol.2022.977941

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 143

  Hansen C. G. Moroishi T. Guan K. L. (2015). YAP and TAZ: A nexus for Hippo signaling and beyond.Trends Cell Biol.25499–513. 10.1016/j.tcb.2015.05.002

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 144

  Hanson L. R. Roeytenberg A. Martinez P. M. Coppes V. G. Sweet D. C. Rao R. J. et al (2009). Intranasal deferoxamine provides increased brain exposure and significant protection in rat ischemic stroke.J. Pharmacol. Exp. Ther.330679–686. 10.1124/jpet.108.149807

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 145

  Hansson E. M. Lendahl U. Chapman G. (2004). Notch signaling in development and disease.Semin. Cancer Biol.14320–328. 10.1016/j.semcancer.2004.04.011

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 146

  Hao D. L. Li J. M. Xie R. Huo H. R. Xiong X. J. Sui F. et al (2023). The role of traditional herbal medicine for ischemic stroke: From bench to clinic-A critical review.Phytomedicine109:154609. 10.1016/j.phymed.2022.154609

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 147

  Hardie G. (2016). Regulation of AMP-activated protein kinase by natural and synthetic activators.Acta Pharm. Sin. B61–19. 10.1016/j.apsb.2015.06.002

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 148

  Harris C. C. (1993). p53: At the crossroads of molecular carcinogenesis and risk assessment.Science2621980–1981. 10.1126/science.8266092

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 149

  Harvey K. F. Pfleger C. M. Hariharan I. K. (2003). The drosophila Mst ortholog, hippo, restricts growth and cell proliferation and promotes apoptosis.Cell114457–467. 10.1016/s0092-8674(03)00557-9

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 150

  Harvey K. F. Zhang X. Thomas D. M. (2013). The Hippo pathway and human cancer.Nat. Rev. Cancer13246–257. 10.1038/nrc3458

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 151

  Hashimoto C. Hudson K. L. Anderson K. V. (1988). The Toll gene of Drosophila, required for dorsal-ventral embryonic polarity, appears to encode a transmembrane protein.Cell52269–279. 10.1016/0092-8674(88)90516-8

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 152

  Hayden M. S. Ghosh S. (2008). Shared principles in NF-kappaB signaling.Cell132344–362.

  • Google Scholar

• 153

  Hayes J. D. Mcmahon M. Chowdhry S. Dinkova-Kostova A. T. (2010). Cancer chemoprevention mechanisms mediated through the Keap1-Nrf2 pathway.Antioxid. Redox Signal.131713–1748.

  • Google Scholar

• 154

  He Q. W. Xia Y. P. Chen S. C. Wang Y. Huang M. Huang Y. et al (2013). Astrocyte-derived sonic hedgehog contributes to angiogenesis in brain microvascular endothelial cells via RhoA/ROCK pathway after oxygen-glucose deprivation.Mol. Neurobiol.47976–987. 10.1007/s12035-013-8396-8

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 155

  He Q. Ma Y. Liu J. Zhang D. Ren J. Zhao R. et al (2021). Biological Functions and Regulatory Mechanisms of Hypoxia-Inducible Factor-1α in Ischemic Stroke.Front. Immunol.12:801985. 10.3389/fimmu.2021.801985

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 156

  He S. Li R. Peng Y. Wang Z. Huang J. Meng H. et al (2022). ACSL4 contributes to ferroptosis-mediated rhabdomyolysis in exertional heat stroke.J. Cachexia Sarcopenia Muscle131717–1730. 10.1002/jcsm.12953

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 157

  Helton R. Cui J. Scheel J. R. Ellison J. A. Ames C. Gibson C. et al (2005). Brain-specific knock-out of hypoxia-inducible factor-1alpha reduces rather than increases hypoxic-ischemic damage.J. Neurosci.254099–4107. 10.1523/JNEUROSCI.4555-04.2005

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 158

  Henke N. Albrecht P. Bouchachia I. Ryazantseva M. Knoll K. Lewerenz J. et al (2013). The plasma membrane channel ORAI1 mediates detrimental calcium influx caused by endogenous oxidative stress.Cell Death Dis.4:e470. 10.1038/cddis.2012.216

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 159

  Herpich F. Rincon F. (2020). Management of Acute Ischemic Stroke.Crit. Care Med.481654–1663.

  • Google Scholar

• 160

  Herr I. Debatin K. M. (2001). Cellular stress response and apoptosis in cancer therapy.Blood982603–2614.

  • Google Scholar

• 161

  Herzig S. Shaw R. J. (2018). AMPK: Guardian of metabolism and mitochondrial homeostasis.Nat. Rev. Mol. Cell Biol.19121–135.

  • Google Scholar

• 162

  Higashida R. T. Tsai F. Y. Halbach V. V. Barnwell S. L. Dowd C. F. Hieshima G. B. (1995). Interventional neurovascular techniques in the treatment of stroke–state-of-the-art therapy.J. Intern. Med.237105–115. 10.1111/j.1365-2796.1995.tb01147.x

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 163

  Hirooka Y. Shimokawa H. (2005). Therapeutic potential of rho-kinase inhibitors in cardiovascular diseases.Am. J. Cardiovasc. Drugs531–39.

  • Google Scholar

• 164

  Hirschhorn T. Stockwell B. R. (2019). The development of the concept of ferroptosis.Free Radic. Biol. Med.133130–143.

  • Google Scholar

• 165

  Hlavica M. Diepers M. Garcia-Esperon C. Ineichen B. V. Nedeltchev K. Kahles T. et al (2015). Pharmacological recanalization therapy in acute ischemic stroke - evolution, current state and perspectives of intravenous and intra-arterial thrombolysis.J. Neuroradiol.4230–46. 10.1016/j.neurad.2014.11.004

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 166

  Ho J. J. Man H. S. Marsden P. A. (2012). Nitric oxide signaling in hypoxia.J. Mol. Med.90217–231.

  • Google Scholar

• 167

  Hollstein M. Sidransky D. Vogelstein B. Harris C. C. (1991). p53 mutations in human cancers.Science25349–53.

  • Google Scholar

• 168

  Homma T. Kobayashi S. Sato H. Fujii J. (2019). Edaravone, a free radical scavenger, protects against ferroptotic cell death in vitro.Exp. Cell Res.384:111592. 10.1016/j.yexcr.2019.111592

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 169

  Hong L. Chen W. He L. Tan H. Peng D. Zhao G. et al (2021). Effect of Naoluoxintong on the NogoA/RhoA/ROCK pathway by down-regulating DNA methylation in MCAO rats.J. Ethnopharmacol.281:114559. 10.1016/j.jep.2021.114559

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 170

  Hou Y. Wang K. Wan W. Cheng Y. Pu X. Ye X. (2018). Resveratrol provides neuroprotection by regulating the JAK2/STAT3/PI3K/AKT/mTOR pathway after stroke in rats.Genes Dis.5245–255. 10.1016/j.gendis.2018.06.001

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 171

  Hsu C. C. Peng D. Cai Z. Lin H. K. (2022). AMPK signaling and its targeting in cancer progression and treatment.Semin. Cancer Biol.8552–68.

  • Google Scholar

• 172

  Hu G. Q. Du X. Li Y. J. Gao X. Q. Chen B. Q. Yu L. (2017). Inhibition of cerebral ischemia/reperfusion injury-induced apoptosis: Nicotiflorin and JAK2/STAT3 pathway.Neural Regen. Res.1296–102. 10.4103/1673-5374.198992

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 173

  Hu Q. Liu L. Zhou L. Lu H. Wang J. Chen X. et al (2020). Effect of fluoxetine on HIF-1α- Netrin/VEGF cascade, angiogenesis and neuroprotection in a rat model of transient middle cerebral artery occlusion.Exp. Neurol.329:113312.

  • Google Scholar

• 174

  Hu Q. Zuo T. Deng L. Chen S. Yu W. Liu S. et al (2022). β-Caryophyllene suppresses ferroptosis induced by cerebral ischemia reperfusion via activation of the NRF2/HO-1 signaling pathway in MCAO/R rats.Phytomedicine102:154112.

  • Google Scholar

• 175

  Hu S. Wu Y. Zhao B. Hu H. Zhu B. Sun Z. et al (2018). Panax notoginseng saponins protect cerebral microvascular endothelial cells against oxygen-glucose deprivation/reperfusion-induced barrier dysfunction via activation of pi3k/akt/nrf2 antioxidant signaling pathway.Molecules23:2781. 10.3390/molecules23112781

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 176

  Hu Y. Zheng Y. Wang T. Jiao L. Luo Y. (2022). VEGF, a key factor for blood brain barrier injury after cerebral ischemic stroke.Aging Dis.13647–654. 10.14336/AD.2021.1121

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 177

  Huang J. Wu S. Barrera J. Matthews K. Pan D. (2005). The Hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the Drosophila Homolog of YAP.Cell122421–434. 10.1016/j.cell.2005.06.007

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 178

  Huang L. Li S. Dai Q. Zhang A. Yu Q. Du W. et al (2020). Astrocytic Yes-associated protein attenuates cerebral ischemia-induced brain injury by regulating signal transducer and activator of transcription 3 signaling.Exp. Neurol.333:113431. 10.1016/j.expneurol.2020.113431

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 179

  Huang S. S. Cheng H. Tang C. M. Nien M. W. Huang Y. S. Lee I. H. et al (2013). Anti-oxidative, anti-apoptotic, and pro-angiogenic effects mediate functional improvement by sonic hedgehog against focal cerebral ischemia in rats.Exp. Neurol.247680–688. 10.1016/j.expneurol.2013.03.004

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 180

  Huang Z. Guo L. Huang L. Shi Y. Liang J. Zhao L. (2021a). Baicalin-loaded macrophage-derived exosomes ameliorate ischemic brain injury via the antioxidative pathway.Mater. Sci. Eng. C Mater. Biol. Appl.126:112123. 10.1016/j.msec.2021.112123

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 181

  Huang Z. Zhou X. Zhang X. Huang L. Sun Y. Cheng Z. et al (2021b). Pien-Tze-Huang, a Chinese patent formula, attenuates NLRP3 inflammasome-related neuroinflammation by enhancing autophagy via the AMPK/mTOR/ULK1 signaling pathway.Biomed. Pharmacother.141:111814. 10.1016/j.biopha.2021.111814

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 182

  Huber O. Korn R. Mclaughlin J. Ohsugi M. Herrmann B. G. Kemler R. (1996). Nuclear localization of beta-catenin by interaction with transcription factor LEF-1.Mech. Dev.593–10.

  • Google Scholar

• 183

  Hui Z. Wang S. Li J. Wang J. Zhang Z. (2022). Compound tongluo decoction inhibits endoplasmic reticulum stress-induced ferroptosis and promoted angiogenesis by activating the Sonic Hedgehog pathway in cerebral infarction.J. Ethnopharmacol.283:114634. 10.1016/j.jep.2021.114634

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 184

  Ignarro L. J. Byrns R. E. Buga G. M. Wood K. S. (1987). Endothelium-derived relaxing factor from pulmonary artery and vein possesses pharmacologic and chemical properties identical to those of nitric oxide radical.Circ. Res.61866–879. 10.1161/01.res.61.6.866

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 185

  Infante P. Alfonsi R. Botta B. Mori M. Di M. (2015). Targeting GLI factors to inhibit the hedgehog pathway.Trends Pharmacol. Sci.36547–558. 10.1016/j.tips.2015.05.006

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 186

  Irving E. A. Barone F. C. Reith A. D. Hadingham S. J. Parsons A. A. (2000). Differential activation of MAPK/ERK and p38/SAPK in neurones and glia following focal cerebral ischaemia in the rat.Brain Res. Mol. Brain Res.7765–75. 10.1016/s0169-328x(00)00043-7

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 187

  Isaacs A. Burke D. C. (1958). Mode of action of interferon.Nature1821073–1074. 10.1038/1821073a0

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 188

  Isago H. Mitani A. Mikami Y. Horie M. Urushiyama H. Hamamoto R. et al (2020). Epithelial expression of YAP and TAZ Is sequentially required in lung development.Am. J. Respir. Cell Mol. Biol.62256–266. 10.1165/rcmb.2019-0218OC

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 189

  Ishikawa H. Tajiri N. Shinozuka K. Vasconcellos J. Kaneko Y. Lee H. J. et al (2013). Vasculogenesis in experimental stroke after human cerebral endothelial cell transplantation.Stroke443473–3481. 10.1161/STROKEAHA.113.001943

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 190

  Issemann I. Green S. (1990). Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators.Nature347645–650. 10.1038/347645a0

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 191

  Ito D. Tanahashi N. Murata M. Sato H. Saito I. Watanabe K. et al (2002). Notch3 gene polymorphism and ischaemic cerebrovascular disease.J. Neurol. Neurosurg. Psychiatry72382–384.

  • Google Scholar

• 192

  Itoh K. Wakabayashi N. Katoh Y. Ishii T. Igarashi K. Engel J. D. et al (1999). Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain.Genes Dev.1376–86. 10.1101/gad.13.1.76

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 193

  Ivan M. Kondo K. Yang H. Kim W. Valiando J. Ohh M. et al (2001). HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: Implications for O2 sensing.Science292464–468. 10.1126/science.1059817

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 194

  Jaakkola P. Mole D. R. Tian Y. M. Wilson M. I. Gielbert J. Gaskell S. J. et al (2001). Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation.Science292468–472. 10.1126/science.1059796

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 195

  Jia J. Cheng J. Ni J. Zhen X. (2015). Neuropharmacological actions of metformin in stroke.Curr. Neuropharmacol.13389–394.

  • Google Scholar

• 196

  Jiang M. Liu X. Zhang D. Wang Y. Hu X. Xu F. et al (2018). Celastrol treatment protects against acute ischemic stroke-induced brain injury by promoting an IL-33/ST2 axis-mediated microglia/macrophage M2 polarization.J. Neuroinflammation15:78. 10.1186/s12974-018-1124-6

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 197

  Jiang S. Li T. Ji T. Yi W. Yang Z. Wang S. et al (2018). AMPK: Potential therapeutic target for ischemic stroke.Theranostics84535–4551.

  • Google Scholar

• 198

  Jiang T. Yu J. T. Zhu X. C. Zhang Q. Q. Tan M. S. Cao L. et al (2015). Ischemic preconditioning provides neuroprotection by induction of AMP-activated protein kinase-dependent autophagy in a rat model of ischemic stroke.Mol. Neurobiol.51220–229. 10.1007/s12035-014-8725-6

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 199

  Jin Y. Barnett A. Zhang Y. Yu X. Luo Y. (2017). Poststroke sonic hedgehog agonist treatment improves functional recovery by enhancing neurogenesis and angiogenesis.Stroke481636–1645. 10.1161/STROKEAHA.117.016650

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 200

  Jovanovic I. P. Pejnovic N. N. Radosavljevic G. D. Arsenijevic N. N. Lukic M. L. (2012). IL-33/ST2 axis in innate and acquired immunity to tumors.Oncoimmunology1229–231.

  • Google Scholar

• 201

  Justice R. W. Zilian O. Woods D. F. Noll M. Bryant P. J. (1995). The Drosophila tumor suppressor gene warts encodes a homolog of human myotonic dystrophy kinase and is required for the control of cell shape and proliferation.Genes Dev.9534–546. 10.1101/gad.9.5.534

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 202

  Justicia C. Gabriel C. Planas A. M. (2000). Activation of the JAK/STAT pathway following transient focal cerebral ischemia: Signaling through Jak1 and Stat3 in astrocytes.Glia30253–270. 10.1002/(sici)1098-1136(200005)30:3<253::aid-glia5>3.0.co;2-o

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 203

  Kader A. Frazzini V. I. Solomon R. A. Trifiletti R. R. (1993). Nitric oxide production during focal cerebral ischemia in rats.Stroke241709–1716.

  • Google Scholar

• 204

  Kang J. S. Liu C. Derynck R. (2009). New regulatory mechanisms of TGF-beta receptor function.Trends Cell Biol.19385–394.

  • Google Scholar

• 205

  Kang R. Zhu S. Zeh H. J. Klionsky D. J. Tang D. (2018). BECN1 is a new driver of ferroptosis.Autophagy142173–2175. 10.1080/15548627.2018.1513758

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 206

  Kango-Singh M. Nolo R. Tao C. Verstreken P. Hiesinger P. R. Bellen H. J. et al (2002). Shar-pei mediates cell proliferation arrest during imaginal disc growth in Drosophila.Development1295719–5730. 10.1242/dev.00168

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 207

  Karaman S. Leppänen V. M. Alitalo K. (2018). Vascular endothelial growth factor signaling in development and disease.Development145:dev151019.

  • Google Scholar

• 208

  Karikó K. Weissman D. Welsh F. A. (2004). Inhibition of toll-like receptor and cytokine signaling–a unifying theme in ischemic tolerance.J. Cereb. Blood Flow Metab.241288–1304. 10.1097/01.WCB.0000145666.68576.71

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 209

  Kawai T. Akira S. (2007). Signaling to NF-kappaB by Toll-like receptors.Trends Mol. Med.13460–469.

  • Google Scholar

• 210

  Kemp B. E. Mitchelhill K. I. Stapleton D. Michell B. J. Chen Z. P. Witters L. A. (1999). Dealing with energy demand: The AMP-activated protein kinase.Trends Biochem. Sci.2422–25. 10.1016/s0968-0004(98)01340-1

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 211

  Khwaja A. Rodriguez-Viciana P. Wennström S. Warne P. H. Downward J. (1997). Matrix adhesion and Ras transformation both activate a phosphoinositide 3-OH kinase and protein kinase B/Akt cellular survival pathway.Embo J.162783–2793. 10.1093/emboj/16.10.2783

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 212

  Kibble M. Saarinen N. Tang J. Wennerberg K. Mäkelä S. Aittokallio T. (2015). Network pharmacology applications to map the unexplored target space and therapeutic potential of natural products.Nat. Prod. Rep.321249–1266. 10.1039/c5np00005j

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 213

  Kidd S. Kelley M. R. Young M. W. (1986). Sequence of the notch locus of Drosophila melanogaster: Relationship of the encoded protein to mammalian clotting and growth factors.Mol. Cell Biol.63094–3108. 10.1128/mcb.6.9.3094-3108.1986

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 214

  Kim H. J. Hawke N. Baldwin A. S. (2006). NF-kappaB and IKK as therapeutic targets in cancer.Cell Death Differ.13738–747.

  • Google Scholar

• 215

  Kishi K. Sasaki T. Kuroda S. Itoh T. Takai Y. (1993). Regulation of cytoplasmic division of Xenopus embryo by rho p21 and its inhibitory GDP/GTP exchange protein (rho GDI).J. Cell Biol.1201187–1195. 10.1083/jcb.120.5.1187

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 216

  Kishore R. Qin G. Luedemann C. Bord E. Hanley A. Silver M. et al (2005). The cytoskeletal protein ezrin regulates EC proliferation and angiogenesis via TNF-alpha-induced transcriptional repression of cyclin A.J. Clin. Invest.1151785–1796. 10.1172/JCI22849

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 217

  Kitada T. Asakawa S. Hattori N. Matsumine H. Yamamura Y. Minoshima S. et al (1998). Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism.Nature392605–608. 10.1038/33416

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 218

  Klaus A. Birchmeier W. (2008). Wnt signalling and its impact on development and cancer.Nat. Rev. Cancer8387–398.

  • Google Scholar

• 219

  Klein C. Westenberger A. (2012). Genetics of Parkinson’s disease.Cold Spring Harb. Perspect. Med.2:a008888.

  • Google Scholar

• 220

  Klempner S. J. Myers A. P. Cantley L. C. (2013). What a tangled web we weave: Emerging resistance mechanisms to inhibition of the phosphoinositide 3-kinase pathway.Cancer Discov.31345–1354. 10.1158/2159-8290.CD-13-0063

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 221

  Konsavage W. M. Jr. Kyler S. L. Rennoll S. A. Jin G. Yochum G. S. (2012). Wnt/β-catenin signaling regulates Yes-associated protein (YAP) gene expression in colorectal carcinoma cells.J. Biol. Chem.28711730–11739.

  • Google Scholar

• 222

  Kraft A. D. Johnson D. A. Johnson J. A. (2004). Nuclear factor E2-related factor 2-dependent antioxidant response element activation by tert-butylhydroquinone and sulforaphane occurring preferentially in astrocytes conditions neurons against oxidative insult.J. Neurosci.241101–1112.

  • Google Scholar

• 223

  Krishnan R. Mays W. Elijovich L. (2021). Complications of mechanical thrombectomy in acute ischemic stroke.Neurology97S115–S125.

  • Google Scholar

• 224

  Krupinski J. Issa R. Bujny T. Slevin M. Kumar P. Kumar S. et al (1997). A putative role for platelet-derived growth factor in angiogenesis and neuroprotection after ischemic stroke in humans.Stroke28564–573. 10.1161/01.str.28.3.564

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 225

  Krupinski J. Kaluza J. Kumar P. Kumar S. Wang J. M. (1994). Role of angiogenesis in patients with cerebral ischemic stroke.Stroke251794–1798.

  • Google Scholar

• 226

  Krupinski J. Kumar P. Kumar S. Kaluza J. (1996). Increased expression of TGF-beta 1 in brain tissue after ischemic stroke in humans.Stroke27852–857.

  • Google Scholar

• 227

  Kumar A. Takada Y. Boriek A. M. Aggarwal B. B. (2004). Nuclear factor-kappaB: Its role in health and disease.J. Mol. Med.82434–448.

  • Google Scholar

• 228

  Lagna G. Hata A. Hemmati-Brivanlou A. Massagué J. (1996). Partnership between DPC4 and SMAD proteins in TGF-beta signalling pathways.Nature383832–836. 10.1038/383832a0

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 229

  Lai M. Wang D. Lin Z. Zhang Y. (2016). Small molecule copper and its relative metabolites in serum of cerebral ischemic stroke patients.J. Stroke Cerebrovasc. Dis.25214–219. 10.1016/j.jstrokecerebrovasdis.2015.09.020

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 230

  Lai Z. C. Wei X. Shimizu T. Ramos E. Rohrbaugh M. Nikolaidis N. et al (2005). Control of cell proliferation and apoptosis by mob as tumor suppressor, mats.Cell120675–685. 10.1016/j.cell.2004.12.036

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 231

  Lapchak P. A. (2002). Development of thrombolytic therapy for stroke: A perspective.Expert Opin. Investig. Drugs111623–1632. 10.1517/13543784.11.11.1623

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 232

  Lapchak P. A. (2010). A critical assessment of edaravone acute ischemic stroke efficacy trials: Is edaravone an effective neuroprotective therapy?Expert Opin. Pharmacother.111753–1763. 10.1517/14656566.2010.493558

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 233

  Lau A. Villeneuve N. F. Sun Z. Wong P. K. Zhang D. D. (2008). Dual roles of Nrf2 in cancer.Pharmacol. Res.58262–270.

  • Google Scholar

• 234

  Lee H. Zandkarimi F. Zhang Y. Meena J. K. Kim J. Zhuang L. et al (2020). Energy-stress-mediated AMPK activation inhibits ferroptosis.Nat. Cell Biol.22225–234. 10.1038/s41556-020-0461-8

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 235

  Lehnardt S. Lehmann S. Kaul D. Tschimmel K. Hoffmann O. Cho S. et al (2007). Toll-like receptor 2 mediates CNS injury in focal cerebral ischemia.J. Neuroimmunol.19028–33. 10.1016/j.jneuroim.2007.07.023

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 236

  Lehnertz K. BRöHL T. Wrede R. V. (2023). Epileptic-network-based prediction and control of seizures in humans.Neurobiol. Dis.181:106098. 10.1016/j.nbd.2023.106098

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 237

  Leker R. R. Aharonowiz M. Greig N. H. Ovadia H. (2004). The role of p53-induced apoptosis in cerebral ischemia: Effects of the p53 inhibitor pifithrin alpha.Exp. Neurol.187478–486. 10.1016/j.expneurol.2004.01.030

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 238

  Lemaitre B. Nicolas E. Michaut L. Reichhart J. M. Hoffmann J. A. (1996). The dorsoventral regulatory gene cassette spätzle/Toll/cactus controls the potent antifungal response in Drosophila adults.Cell86973–983. 10.1016/s0092-8674(00)80172-5

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 239

  Leung D. W. Cachianes G. Kuang W. J. Goeddel D. V. Ferrara N. (1989). Vascular endothelial growth factor is a secreted angiogenic mitogen.Science2461306–1309. 10.1126/science.2479986

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 240

  Leung S. W. Lai J. H. Wu J. C. Tsai Y. R. Chen Y. H. Kang S. J. et al (2020). Neuroprotective effects of emodin against ischemia/reperfusion injury through activating ERK-1/2 signaling pathway.Int. J. Mol. Sci.21:2899. 10.3390/ijms21082899

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 241

  Levine A. J. (2020). p53: 800 million years of evolution and 40 years of discovery.Nat. Rev. Cancer20471–480. 10.1038/s41568-020-0262-1

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 242

  Levine A. J. Momand J. Finlay C. A. (1991). The p53 tumour suppressor gene.Nature351453–456.

  • Google Scholar

• 243

  Lezoualc’h F. Behl C. (1998). Transcription factor NF-kappaB: Friend or foe of neurons?Mol. Psychiatry315–20. 10.1038/sj.mp.4000295

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 244

  Li C. Dong X. Du W. Shi X. Chen K. Zhang W. et al (2020). LKB1-AMPK axis negatively regulates ferroptosis by inhibiting fatty acid synthesis.Signal. Transduct. Target Ther.5:187. 10.1038/s41392-020-00297-2

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 245

  Li C. Sui C. Wang W. Yan J. Deng N. Du X. et al (2021). Baicalin attenuates oxygen-glucose deprivation/reoxygenation-induced injury by modulating the BDNF-TrkB/PI3K/Akt and MAPK/Erk1/2 signaling axes in neuron-astrocyte cocultures.Front. Pharmacol.12:599543. 10.3389/fphar.2021.599543

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 246

  Li D. Ni H. Rui Q. Gao R. Chen G. (2018). Mst1: Function and mechanism in brain and myocardial ischemia reperfusion injury.Curr. Neuropharmacol.161358–1364. 10.2174/1570159X16666180516095949

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 247

  Li J. Cao F. Yin H. L. Huang Z. J. Lin Z. T. Mao N. et al (2020). Ferroptosis: Past, present and future.Cell Death Dis.11:88.

  • Google Scholar

• 248

  Li J. Zeng Z. Viollet B. Ronnett G. V. Mccullough L. D. (2007). Neuroprotective effects of adenosine monophosphate-activated protein kinase inhibition and gene deletion in stroke.Stroke382992–2999. 10.1161/STROKEAHA.107.490904

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 249

  Li L. Sun L. Qiu Y. Zhu W. Hu K. Mao J. (2020). Protective effect of stachydrine against cerebral ischemia-reperfusion injury by reducing inflammation and apoptosis through P65 and JAK2/STAT3 signaling pathway.Front. Pharmacol.11:64. 10.3389/fphar.2020.00064

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 250

  Li M. Meng Z. Yu S. Li J. Wang Y. Yang W. et al (2022). Baicalein ameliorates cerebral ischemia-reperfusion injury by inhibiting ferroptosis via regulating GPX4/ACSL4/ACSL3 axis.Chem. Biol. Interact.366:110137. 10.1016/j.cbi.2022.110137

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 251

  Li N. Jiang W. Wang W. Xiong R. Wu X. Geng Q. (2021). Ferroptosis and its emerging roles in cardiovascular diseases.Pharmacol. Res.166:105466.

  • Google Scholar

• 252

  Li Q. Q. Ding D. H. Wang X. Y. Sun Y. Y. Wu J. (2021). Lipoxin A4 regulates microglial M1/M2 polarization after cerebral ischemia-reperfusion injury via the Notch signaling pathway.Exp. Neurol.339:113645. 10.1016/j.expneurol.2021.113645

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 253

  Li Q. Han X. Lan X. Gao Y. Wan J. Durham F. et al (2017). Inhibition of neuronal ferroptosis protects hemorrhagic brain.JCI Insight2:e90777.

  • Google Scholar

• 254

  Li Y. Chopp M. Zhang Z. G. Zaloga C. Niewenhuis L. Gautam S. (1994). p53-immunoreactive protein and p53 mRNA expression after transient middle cerebral artery occlusion in rats.Stroke25849–855. 10.1161/01.str.25.4.849

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 255

  Li Y. Suo L. Liu Y. Li H. Xue W. (2017). Protective effects of ginsenoside Rg1 against oxygen-glucose-deprivation-induced apoptosis in neural stem cells.J. Neurol. Sci.373107–112. 10.1016/j.jns.2016.12.036

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 256

  Li Y. Zhu Z. Y. Lu B. W. Huang T. T. Zhang Y. M. Zhou N. Y. et al (2019). Rosiglitazone ameliorates tissue plasminogen activator-induced brain hemorrhage after stroke.CNS Neurosci. Ther.251343–1352. 10.1111/cns.13260

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 257

  Li Z. Yan Z. Xu C. Dong Y. Xiong Y. Dai Y. (2018). Acetylshikonin attenuates angiotensin II-induced proliferation and motility of human brain smooth muscle cells by inhibiting Wnt/β-catenin signaling.Hum. Cell31242–250.

  • Google Scholar

• 258

  Lian I. Kim J. Okazawa H. Zhao J. Zhao B. Yu J. et al (2010). The role of YAP transcription coactivator in regulating stem cell self-renewal and differentiation.Genes Dev.241106–1118.

  • Google Scholar

• 259

  Liang C. Ni G. X. Shi X. L. Jia L. Wang Y. L. (2020). Astragaloside IV regulates the HIF/VEGF/Notch signaling pathway through miRNA-210 to promote angiogenesis after ischemic stroke.Restor. Neurol. Neurosci.38271–282. 10.3233/RNN-201001

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 260

  Liu C. He P. Guo Y. Tian Q. Wang J. Wang G. et al (2022). Taurine attenuates neuronal ferroptosis by regulating GABA(B)/AKT/GSK3β/β-catenin pathway after subarachnoid hemorrhage.Free Radic. Biol. Med.193795–807.

  • Google Scholar

• 261

  Liu F. Hata A. Baker J. C. Doody J. Cárcamo J. Harland R. M. et al (1996). A human Mad protein acting as a BMP-regulated transcriptional activator.Nature381620–623. 10.1038/381620a0

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 262

  Liu H. Wu X. Luo J. Wang X. Guo H. Feng D. et al (2019). Pterostilbene attenuates astrocytic inflammation and neuronal oxidative injury after ischemia-reperfusion by inhibiting NF-κB phosphorylation.Front. Immunol.10:2408. 10.3389/fimmu.2019.02408

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 263

  Liu J. Wang L. N. (2017). Peroxisome proliferator-activated receptor gamma agonists for preventing recurrent stroke and other vascular events in people with stroke or transient ischaemic attack.Cochrane Database Syst. Rev.12:Cd010693.

  • Google Scholar

• 264

  Liu T. Ding Y. Wen A. (2018). Traditional Chinese medicine for ischaemic stroke.Lancet Neurol.17:745.

  • Google Scholar

• 265

  Liu Y. Tang G. Li Y. Wang Y. Chen X. Gu X. et al (2014). Metformin attenuates blood-brain barrier disruption in mice following middle cerebral artery occlusion.J. Neuroinflammation11:177. 10.1186/s12974-014-0177-4

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 266

  Liu Z. Zhou Z. Ai P. Zhang C. Chen J. Wang Y. (2022). Astragaloside IV attenuates ferroptosis after subarachnoid hemorrhage via Nrf2/HO-1 signaling pathway.Front. Pharmacol.13:924826. 10.3389/fphar.2022.924826

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 267

  Lou Y. Ma M. Jiang Y. Xu H. Gao Z. Gao L. et al (2022). Ferroptosis: A new strategy for traditional Chinese medicine treatment of stroke.Biomed. Pharmacother.156:113806.

  • Google Scholar

• 268

  Louandre C. Ezzoukhry Z. Godin C. Barbare J. C. Mazière J. C. Chauffert B. et al (2013). Iron-dependent cell death of hepatocellular carcinoma cells exposed to sorafenib.Int. J. Cancer1331732–1742. 10.1002/ijc.28159

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 269

  Lu W. Chen Z. Wen J. (2021). RhoA/ROCK signaling pathway and astrocytes in ischemic stroke.Metab. Brain Dis.361101–1108. 10.1007/s11011-021-00709-4

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 270

  Luo Y. Kuo C. C. Shen H. Chou J. Greig N. H. Hoffer B. J. et al (2009). Delayed treatment with a p53 inhibitor enhances recovery in stroke brain.Ann. Neurol.65520–530.

  • Google Scholar

• 271

  Luo Y. Yin W. Signore A. P. Zhang F. Hong Z. Wang S. et al (2006). Neuroprotection against focal ischemic brain injury by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone.J. Neurochem.97435–448.

  • Google Scholar

• 272

  Lv H. Liu X. Zeng X. Liu Y. Zhang C. Zhang Q. et al (2022). Comprehensive analysis of cuproptosis-related genes in immune infiltration and prognosis in melanoma.Front. Pharmacol.13:930041. 10.3389/fphar.2022.930041

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 273

  Madaule P. Axel R. (1985). A novel ras-related gene family.Cell4131–40.

  • Google Scholar

• 274

  Mao Z. Tian L. Liu J. Wu Q. Wang N. Wang G. et al (2022). Ligustilide ameliorates hippocampal neuronal injury after cerebral ischemia reperfusion through activating PINK1/Parkin-dependent mitophagy.Phytomedicine101:154111. 10.1016/j.phymed.2022.154111

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 275

  Martí-Carvajal A. J. Valli C. Martí-Amarista C. E. Solà I. Martí-Fàbregas J. Bonfill C. (2020). Citicoline for treating people with acute ischemic stroke.Cochrane Database Syst. Rev.8:Cd013066.

  • Google Scholar

• 276

  Mastroiacovo F. Busceti C. L. Biagioni F. Moyanova S. G. Meisler M. H. Battaglia G. et al (2009). Induction of the Wnt antagonist, Dickkopf-1, contributes to the development of neuronal death in models of brain focal ischemia.J. Cereb. Blood Flow Metab.29264–276. 10.1038/jcbfm.2008.111

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 277

  Matise M. P. Joyner A. L. (1999). Gli genes in development and cancer.Oncogene187852–7859.

  • Google Scholar

• 278

  Matsuda N. Sato S. Shiba K. Okatsu K. Saisho K. Gautier C. A. et al (2010). PINK1 stabilized by mitochondrial depolarization recruits Parkin to damaged mitochondria and activates latent Parkin for mitophagy.J. Cell Biol.189211–221. 10.1083/jcb.200910140

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 279

  Matsushima M. Fujiwara T. Takahashi E. Minaguchi T. Eguchi Y. Tsujimoto Y. et al (1998). Isolation, mapping, and functional analysis of a novel human cDNA (BNIP3L) encoding a protein homologous to human NIP3.Genes Chromosomes Cancer21230–235.

  • Pubmed Abstract
  • Google Scholar

• 280

  Mccrea P. D. Turck C. W. Gumbiner B. (1991). A homolog of the armadillo protein in Drosophila (plakoglobin) associated with E-cadherin.Science2541359–1361. 10.1126/science.1962194

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 281

  Mccullough L. D. Zeng Z. Li H. Landree L. E. Mcfadden J. Ronnett G. V. (2005). Pharmacological inhibition of AMP-activated protein kinase provides neuroprotection in stroke.J. Biol. Chem.28020493–20502.

  • Google Scholar

• 282

  Mcmahon G. (2000). VEGF receptor signaling in tumor angiogenesis.Oncologist53–10.

  • Google Scholar

• 283

  Menet R. Lecordier S. Elali A. (2020). Wnt Pathway: An emerging player in vascular and traumatic mediated brain injuries.Front. Physiol.11:565667. 10.3389/fphys.2020.565667

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 284

  Meng Z. Moroishi T. Guan K. L. (2016). Mechanisms of Hippo pathway regulation.Genes Dev.301–17.

  • Google Scholar

• 285

  Mengesdorf T. Jensen P. H. Mies G. Aufenberg C. Paschen W. (2002). Down-regulation of parkin protein in transient focal cerebral ischemia: A link between stroke and degenerative disease?Proc. Natl. Acad. Sci. U. S. A.9915042–15047. 10.1073/pnas.232588799

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 286

  Metz C. W. Bridges C. B. (1917). Incompatibility of mutant races in drosophila.Proc. Natl. Acad. Sci. U. S. A.3673–678. 10.1073/pnas.3.12.673

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 287

  Mi D. H. Fang H. J. Zheng G. H. Liang X. H. Ding Y. R. Liu X. et al (2019). DPP-4 inhibitors promote proliferation and migration of rat brain microvascular endothelial cells under hypoxic/high-glucose conditions, potentially through the SIRT1/HIF-1/VEGF pathway.CNS Neurosci. Ther.25323–332. 10.1111/cns.13042

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 288

  Minhas J. S. Chithiramohan T. Wang X. Barnes S. C. Clough R. H. Kadicheeni M. et al (2022). Oral antiplatelet therapy for acute ischaemic stroke.Cochrane Database Syst. Rev.1:Cd000029.

  • Google Scholar

• 289

  Mirończuk A. Kapica-Topczewska K. Socha K. Soroczyńska J. Jamiołkowski J. Kułakowska A. et al (2021). Selenium, copper, zinc concentrations and Cu/Zn, Cu/Se molar ratios in the serum of patients with acute ischemic stroke in northeastern poland-a new insight into stroke pathophysiology.Nutrients13:2139. 10.3390/nu13072139

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 290

  Moi P. Chan K. Asunis I. Cao A. Kan Y. W. (1994). Isolation of NF-E2-related factor 2 (Nrf2), a NF-E2-like basic leucine zipper transcriptional activator that binds to the tandem NF-E2/AP1 repeat of the beta-globin locus control region.Proc. Natl. Acad. Sci. U. S. A.919926–9930. 10.1073/pnas.91.21.9926

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 291

  Morii N. Sekine A. Ohashi Y. Nakao K. Imura H. Fujiwara M. et al (1988). Purification and properties of the cytosolic substrate for botulinum ADP-ribosyltransferase. Identification as an Mr 22,000 guanine nucleotide-binding protein.J. Biol. Chem.26312420–12426.

  • Pubmed Abstract
  • Google Scholar

• 292

  Moroishi T. Hansen C. G. Guan K. L. (2015). The emerging roles of YAP and TAZ in cancer.Nat. Rev. Cancer1573–79.

  • Google Scholar

• 293

  Moya I. M. Halder G. (2019). Hippo-YAP/TAZ signalling in organ regeneration and regenerative medicine.Nat. Rev. Mol. Cell Biol.20211–226. 10.1038/s41580-018-0086-y

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 294

  Muller P. A. Vousden K. H. (2014). Mutant p53 in cancer: New functions and therapeutic opportunities.Cancer Cell25304–317.

  • Google Scholar

• 295

  Munday M. R. Campbell D. G. Carling D. Hardie D. G. (1988). Identification by amino acid sequencing of three major regulatory phosphorylation sites on rat acetyl-CoA carboxylase.Eur. J. Biochem.175331–338. 10.1111/j.1432-1033.1988.tb14201.x

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 296

  Nalamolu K. R. Challa S. R. Fornal C. A. Grudzien N. A. Jorgenson L. C. Choudry M. M. et al (2021). Attenuation of the Induction of TLRs 2 and 4 mitigates inflammation and promotes neurological recovery after focal cerebral ischemia.Transl. Stroke Res.12923–936. 10.1007/s12975-020-00884-z

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 297

  Narumiya S. Sekine A. Fujiwara M. (1988). Substrate for botulinum ADP-ribosyltransferase, Gb, has an amino acid sequence homologous to a putative rho gene product.J. Biol. Chem.26317255–17257.

  • Pubmed Abstract
  • Google Scholar

• 298

  Ni J. Yao M. Wang L. H. Yu M. Li R. H. Zhao L. H. et al (2021). Human urinary kallidinogenase in acute ischemic stroke: A single-arm, multicenter, phase IV study (RESK study).CNS Neurosci. Ther.271493–1503.

  • Google Scholar

• 299

  Nitatori T. Sato N. Waguri S. Karasawa Y. Araki H. Shibanai K. et al (1995). Delayed neuronal death in the CA1 pyramidal cell layer of the gerbil hippocampus following transient ischemia is apoptosis.J. Neurosci.151001–1011.

  • Google Scholar

• 300

  Nomura N. Miyajima N. Sazuka T. Tanaka A. Kawarabayasi Y. Sato S. et al (1994). Prediction of the coding sequences of unidentified human genes. I. The coding sequences of 40 new genes (KIAA0001-KIAA0040) deduced by analysis of randomly sampled cDNA clones from human immature myeloid cell line KG-1 (supplement).DNA Res.147–56. 10.1093/dnares/1.1.47

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 301

  Noordermeer J. Klingensmith J. Perrimon N. Nusse R. (1994). Dishevelled and armadillo act in the wingless signalling pathway in Drosophila.Nature36780–83.

  • Google Scholar

• 302

  Nusse R. (2005). Wnt signaling in disease and in development.Cell Res.1528–32.

  • Google Scholar

• 303

  Nusse R. Varmus H. E. (1982). Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome.Cell3199–109.

  • Google Scholar

• 304

  Nusse R. Brown A. Papkoff J. Scambler P. Shackleford G. Mcmahon A. et al (1991). A new nomenclature for int-1 and related genes: The Wnt gene family.Cell64:231. 10.1016/0092-8674(91)90633-a

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 305

  Nüsslein-Volhard C. Wieschaus E. (1980). Mutations affecting segment number and polarity in Drosophila.Nature287795–801.

  • Google Scholar

• 306

  Oda T. Elkahloun A. G. Pike B. L. Okajima K. Krantz I. D. Genin A. et al (1997). Mutations in the human Jagged1 gene are responsible for Alagille syndrome.Nat. Genet.16235–242.

  • Google Scholar

• 307

  Ohashi Y. Narumiya S. (1987). ADP-ribosylation of a Mr 21,000 membrane protein by type D botulinum toxin.J. Biol. Chem.2621430–1433.

  • Google Scholar

• 308

  O’Neill L. A. Hardie D. G. (2013). Metabolism of inflammation limited by AMPK and pseudo-starvation.Nature493346–355. 10.1038/nature11862

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 309

  O’Rourke F. Dean N. Akhtar N. Shuaib A. (2004). Current and future concepts in stroke prevention.CMAJ1701123–1133.

  • Google Scholar

• 310

  O’Shea J. J. Murray P. J. (2008). Cytokine signaling modules in inflammatory responses.Immunity28477–487.

  • Google Scholar

• 311

  Pahl H. L. (1999). Activators and target genes of Rel/NF-kappaB transcription factors.Oncogene186853–6866.

  • Google Scholar

• 312

  Palmer G. Gabay C. (2011). Interleukin-33 biology with potential insights into human diseases.Nat. Rev. Rheumatol.7321–329.

  • Google Scholar

• 313

  Palmer R. M. Ferrige A. G. Moncada S. (1987). Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor.Nature327524–526.

  • Google Scholar

• 314

  Pan B. Sun J. Liu Z. Wang L. Huo H. Zhao Y. et al (2021). Longxuetongluo capsule protects against cerebral ischemia/reperfusion injury through endoplasmic reticulum stress and MAPK-mediated mechanisms.J. Adv. Res.33215–225. 10.1016/j.jare.2021.01.016

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 315

  Pantalacci S. Tapon N. Léopold P. (2003). The Salvador partner Hippo promotes apoptosis and cell-cycle exit in Drosophila.Nat. Cell Biol.5921–927. 10.1038/ncb1051

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 316

  Park H. W. Kim Y. C. Yu B. Moroishi T. Mo J. S. Plouffe S. W. et al (2015). Alternative Wnt signaling activates YAP/TAZ.Cell162780–794.

  • Google Scholar

• 317

  Pepicelli C. V. Lewis P. M. Mcmahon A. P. (1998). Sonic hedgehog regulates branching morphogenesis in the mammalian lung.Curr. Biol.81083–1086.

  • Google Scholar

• 318

  Philips R. L. Wang Y. Cheon H. Kanno Y. Gadina M. Sartorelli V. et al (2022). The JAK-STAT pathway at 30: Much learned, much more to do.Cell1853857–3876. 10.1016/j.cell.2022.09.023

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 319

  Pikarsky E. Porat R. M. Stein I. Abramovitch R. Amit S. Kasem S. et al (2004). NF-kappaB functions as a tumour promoter in inflammation-associated cancer.Nature431461–466.

  • Google Scholar

• 320

  Pobbati A. V. Hong W. (2020). A combat with the YAP/TAZ-TEAD oncoproteins for cancer therapy.Theranostics103622–3635. 10.7150/thno.40889

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 321

  Powers W. J. Rabinstein A. A. Ackerson T. Adeoye O. M. Bambakidis N. C. Becker K. et al (2019). Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: A guideline for healthcare professionals from the american heart association/american stroke association.Stroke50e344–e418.

  • Google Scholar

• 322

  Qin C. Yang S. Chu Y. H. Zhang H. Pang X. W. Chen L. et al (2022). Signaling pathways involved in ischemic stroke: Molecular mechanisms and therapeutic interventions.Signal. Transduct. Target Ther.7215.

  • Google Scholar

• 323

  Ran Y. Su W. Gao F. Ding Z. Yang S. Ye L. et al (2021). Curcumin ameliorates white matter injury after ischemic stroke by inhibiting microglia/macrophage pyroptosis through NF-κB suppression and NLRP3 inflammasome inhibition.Oxid. Med. Cell Longev.2021:1552127.

  • Google Scholar

• 324

  Ratan R. R. Murphy T. H. Baraban J. M. (1994). Macromolecular synthesis inhibitors prevent oxidative stress-induced apoptosis in embryonic cortical neurons by shunting cysteine from protein synthesis to glutathione.J. Neurosci.144385–4392. 10.1523/JNEUROSCI.14-07-04385.1994

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 325

  Ray L. B. Sturgill T. W. (1988). Insulin-stimulated microtubule-associated protein kinase is phosphorylated on tyrosine and threonine in vivo.Proc. Natl. Acad. Sci. U. S. A.853753–3757. 10.1073/pnas.85.11.3753

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 326

  Ridley A. J. Hall A. (1992). The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors.Cell70389–399. 10.1016/0092-8674(92)90163-7

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 327

  Ridnour L. A. Cheng R. Y. Switzer C. H. Heinecke J. L. Ambs S. Glynn S. et al (2013). Molecular pathways: Toll-like receptors in the tumor microenvironment–poor prognosis or new therapeutic opportunity.Clin. Cancer Res.191340–1346. 10.1158/1078-0432.CCR-12-0408

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 328

  Rijken D. C. Collen D. (1981). Purification and characterization of the plasminogen activator secreted by human melanoma cells in culture.J. Biol. Chem.2567035–7041. 10.1016/S0021-9258(19)69095-2

  • CrossRef
  • Google Scholar

• 329

  Rikitake Y. Kim H. H. Huang Z. Seto M. Yano K. Asano T. et al (2005). Inhibition of Rho kinase (ROCK) leads to increased cerebral blood flow and stroke protection.Stroke362251–2257. 10.1161/01.STR.0000181077.84981.11

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 330

  Roberts A. B. Anzano M. A. Wakefield L. M. Roche N. S. Stern D. F. Sporn M. B. (1985). Type beta transforming growth factor: A bifunctional regulator of cellular growth.Proc. Natl. Acad. Sci. U. S. A.82119–123. 10.1073/pnas.82.1.119

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 331

  Ronkina N. Gaestel M. (2022). MAPK-activated protein kinases: Servant or partner?Annu. Rev. Biochem.91505–540. 10.1146/annurev-biochem-081720-114505

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 332

  Salminen A. Kaarniranta K. (2012). AMP-activated protein kinase (AMPK) controls the aging process via an integrated signaling network.Ageing Res. Rev.11230–241. 10.1016/j.arr.2011.12.005

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 333

  Sandercock P. A. Counsell C. Kamal A. K. (2008). Anticoagulants for acute ischaemic stroke.Cochrane Database Syst. Rev.10:Cd000024. 10.1002/14651858.CD000024.pub3

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 334

  Sarfo F. S. Nichols M. Opare-Addo P. A. Ovbiagele B. (2023). Polypill programs to prevent stroke and cut costs in low income countries: Moving from clinical efficacy to pragmatic implementation.Stroke54407–414. 10.1161/STROKEAHA.122.039567

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 335

  Sarin A. Marcel N. (2017). The NOTCH1-autophagy interaction: Regulating self-eating for survival.Autophagy13446–447. 10.1080/15548627.2016.1268303

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 336

  Sasaki H. Nishizaki Y. Hui C. Nakafuku M. Kondoh H. (1999). Regulation of Gli2 and Gli3 activities by an amino-terminal repression domain: Implication of Gli2 and Gli3 as primary mediators of Shh signaling.Development1263915–3924. 10.1242/dev.126.17.3915

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 337

  Sawe N. Steinberg G. Zhao H. (2008). Dual roles of the MAPK/ERK1/2 cell signaling pathway after stroke.J. Neurosci. Res.861659–1669. 10.1002/jnr.21604

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 338

  Schindler C. W. (2002). Series introduction. JAK-STAT signaling in human disease.J. Clin. Invest.1091133–1137. 10.1172/JCI0215644

  • CrossRef
  • Google Scholar

• 339

  Schmitz J. Owyang A. Oldham E. Song Y. Murphy E. Mcclanahan T. K. et al (2005). IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines.Immunity23479–490. 10.1016/j.immuni.2005.09.015

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 340

  Schneider A. Martin-Villalba A. Weih F. Vogel J. Wirth T. Schwaninger M. (1999). NF-kappaB is activated and promotes cell death in focal cerebral ischemia.Nat. Med.5554–559. 10.1038/8432

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 341

  Seger R. Krebs E. G. (1995). The MAPK signaling cascade.Faseb J.9726–735.

  • Google Scholar

• 342

  Seiler A. Schneider M. FöRSTER H. Roth S. Wirth E. K. Culmsee C. et al (2008). Glutathione peroxidase 4 senses and translates oxidative stress into 12/15-lipoxygenase dependent- and AIF-mediated cell death.Cell Metab.8237–248. 10.1016/j.cmet.2008.07.005

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 343

  Semenza G. L. Nejfelt M. K. Chi S. M. Antonarakis S. E. (1991). Hypoxia-inducible nuclear factors bind to an enhancer element located 3’ to the human erythropoietin gene.Proc. Natl. Acad. Sci. U. S. A.885680–5684. 10.1073/pnas.88.13.5680

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 344

  Sen R. Baltimore D. (1986). Multiple nuclear factors interact with the immunoglobulin enhancer sequences.Cell46705–716.

  • Google Scholar

• 345

  Senger D. R. Galli S. J. Dvorak A. M. Perruzzi C. A. Harvey V. S. Dvorak H. F. (1983). Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid.Science219983–985. 10.1126/science.6823562

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 346

  Shariati M. Meric-Bernstam F. (2019). Targeting AKT for cancer therapy.Expert. Opin. Investig. Drugs28977–988. 10.1080/13543784.2019.1676726

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 347

  Shi L. Yuan Y. Xiao Y. Long P. Li W. Yu Y. et al (2021). Associations of plasma metal concentrations with the risks of all-cause and cardiovascular disease mortality in Chinese adults.Environ. Int.157:106808. 10.1016/j.envint.2021.106808

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 348

  Shi S. Wang M. Liu X. Han S. Zhu P. (2022). Scalp electroacupuncture promotes angiogenesis after stroke in rats by activation of Wnt/β-catenin signal pathway.Evid. Based Complement Alternat. Med.2022:1649605.

  • Google Scholar

• 349

  Shibuya M. Hirai S. Seto M. Satoh S. Ohtomo E. (2005). Effects of fasudil in acute ischemic stroke: Results of a prospective placebo-controlled double-blind trial.J. Neurol. Sci.23831–39. 10.1016/j.jns.2005.06.003

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 350

  Shih A. Y. Li P. Murphy T. H. (2005). A small-molecule-inducible Nrf2-mediated antioxidant response provides effective prophylaxis against cerebral ischemia in vivo.J. Neurosci.2510321–10335. 10.1523/JNEUROSCI.4014-05.2005

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 351

  Shim J. W. Madsen J. R. (2018). VEGF signaling in neurological disorders.Int. J. Mol. Sci.19:275.

  • Google Scholar

• 352

  Shimokawa H. Takeshita A. (2005). Rho-kinase is an important therapeutic target in cardiovascular medicine.Arterioscler. Thromb. Vasc. Biol.251767–1775.

  • Google Scholar

• 353

  Shin H. K. Salomone S. Potts E. M. Lee S. W. Millican E. Noma K. et al (2007). Rho-kinase inhibition acutely augments blood flow in focal cerebral ischemia via endothelial mechanisms.J. Cereb. Blood Flow Metab.27998–1009. 10.1038/sj.jcbfm.9600406

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 354

  Shruster A. Ben-Zur T. Melamed E. Offen D. (2012). Wnt signaling enhances neurogenesis and improves neurological function after focal ischemic injury.PLoS One7:e40843. 10.1371/journal.pone.0040843

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 355

  Siegfried E. Wilder E. L. Perrimon N. (1994). Components of wingless signalling in Drosophila.Nature36776–80.

  • Google Scholar

• 356

  Sim A. T. Hardie D. G. (1988). The low activity of acetyl-CoA carboxylase in basal and glucagon-stimulated hepatocytes is due to phosphorylation by the AMP-activated protein kinase and not cyclic AMP-dependent protein kinase.FEBS Lett.233294–298. 10.1016/0014-5793(88)80445-9

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 357

  Singh N. Menon B. K. Dmytriw A. A. Regenhardt R. W. Hirsch J. A. Ganesh A. (2023). Replacing alteplase with tenecteplase: Is the time ripe?J. Stroke2572–80. 10.5853/jos.2022.02880

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 358

  Son T. G. Camandola S. Arumugam T. V. Cutler R. G. Telljohann R. S. Mughal M. R. et al (2010). Plumbagin, a novel Nrf2/ARE activator, protects against cerebral ischemia.J. Neurochem.1121316–1326. 10.1111/j.1471-4159.2009.06552.x

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 359

  Song X. Zhu S. Chen P. Hou W. Wen Q. Liu J. et al (2018). AMPK-mediated BECN1 phosphorylation promotes ferroptosis by directly blocking system X(c)(-) activity.Curr. Biol.282388–2399e5. 10.1016/j.cub.2018.05.094

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 360

  Speer R. E. Karuppagounder S. S. Basso M. Sleiman S. F. Kumar A. Brand D. et al (2013). Hypoxia-inducible factor prolyl hydroxylases as targets for neuroprotection by “antioxidant” metal chelators: From ferroptosis to stroke.Free Radic. Biol. Med.6226–36. 10.1016/j.freeradbiomed.2013.01.026

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 361

  Stark G. R. Darnell J. E. Jr. (2012). The JAK-STAT pathway at twenty.Immunity36503–514.

  • Google Scholar

• 362

  Stockwell B. R. Friedmann A. Bayir H. Bush A. I. Conrad M. Dixon S. J. et al (2017). Ferroptosis: A regulated cell death nexus linking metabolism, redox biology, and disease.Cell171273–285.

  • Google Scholar

• 363

  Sun E. Zhang J. Deng Y. Wang J. Wu Q. Chen W. et al (2022). Docosahexaenoic acid alleviates brain damage by promoting mitophagy in mice with ischaemic stroke.Oxid. Med. Cell Longev.2022:3119649. 10.1155/2022/3119649

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 364

  Sun F. L. Wang W. Zuo W. Xue J. L. Xu J. D. Ai H. X. et al (2014). Promoting neurogenesis via Wnt/β-catenin signaling pathway accounts for the neurorestorative effects of morroniside against cerebral ischemia injury.Eur. J. Pharmacol.738214–221.

  • Google Scholar

• 365

  Sun L. Zhang H. Wang W. Chen Z. Wang S. Li J. et al (2020). Astragaloside IV exerts cognitive benefits and promotes hippocampal neurogenesis in stroke mice by downregulating interleukin-17 expression via wnt pathway.Front. Pharmacol.11:421. 10.3389/fphar.2020.00421

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 366

  Sun Z. Da F. Moreno M. Holton N. E. Sweat M. Sweat Y. et al (2018). FoxO6 regulates Hippo signaling and growth of the craniofacial complex.PLoS Genet.14:e1007675. 10.1371/journal.pgen.1007675

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 367

  Suzuki S. Tanaka K. Nogawa S. Dembo T. Kosakai A. Fukuuchi Y. (2001). Phosphorylation of signal transducer and activator of transcription-3 (Stat3) after focal cerebral ischemia in rats.Exp. Neurol.17063–71.

  • Google Scholar

• 368

  Szabo C. (2017). Hydrogen sulfide, an enhancer of vascular nitric oxide signaling: Mechanisms and implications.Am. J. Physiol. Cell Physiol.312C3–C15.

  • Google Scholar

• 369

  Tachibana E. Harada T. Shibuya M. Saito K. Takayasu M. Suzuki Y. et al (1999). Intra-arterial infusion of fasudil hydrochloride for treating vasospasm following subarachnoid haemorrhage.Acta Neurochir.14113–19.

  • Google Scholar

• 370

  Tam J. P. Marquardt H. Rosberger D. F. Wong T. W. Todaro G. J. (1984). Synthesis of biologically active rat transforming growth factor I.Nature309376–378.

  • Google Scholar

• 371

  Tan J. Luo J. Meng C. Jiang N. Cao J. Zhao J. (2021). Syringin exerts neuroprotective effects in a rat model of cerebral ischemia through the FOXO3a/NF-κB pathway.Int. Immunopharmacol.90:107268.

  • Google Scholar

• 372

  Tang C. Hong J. Hu C. Huang C. Gao J. Huang J. et al (2021). Palmatine protects against cerebral ischemia/reperfusion injury by activation of the AMPK/Nrf2 pathway.Oxid. Med. Cell Longev.2021:6660193. 10.1155/2021/6660193

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 373

  Tang D. Chen X. Kroemer G. (2022). Cuproptosis: A copper-triggered modality of mitochondrial cell death.Cell Res.32417–418.

  • Google Scholar

• 374

  Tang J. Hu Z. Tan J. Yang S. Zeng L. (2016). Parkin protects against oxygen-glucose deprivation/reperfusion insult by promoting Drp1 degradation.Oxid. Med. Cell Longev.2016:8474303. 10.1155/2016/8474303

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 375

  Tang S. C. Yeh S. J. Li Y. I. Wang Y. C. Baik S. H. Santro T. et al (2013). Evidence for a detrimental role of TLR8 in ischemic stroke.Exp. Neurol.250341–347. 10.1016/j.expneurol.2013.10.012

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 376

  Tao G. Kahr P. C. Morikawa Y. Zhang M. Rahmani M. Heallen T. R. et al (2016). Pitx2 promotes heart repair by activating the antioxidant response after cardiac injury.Nature534119–123. 10.1038/nature17959

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 377

  Tapon N. Harvey K. F. Bell D. W. Wahrer D. C. Schiripo T. A. Haber D. et al (2002). Salvador promotes both cell cycle exit and apoptosis in Drosophila and is mutated in human cancer cell lines.Cell110467–478. 10.1016/s0092-8674(02)00824-3

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 378

  Taylor J. M. Cohen S. Mitchell W. M. (1970). Epidermal growth factor: High and low molecular weight forms.Proc. Natl. Acad. Sci. U. S. A.67164–171.

  • Google Scholar

• 379

  Thompson C. B. (2016). Into thin air: How we sense and respond to hypoxia.Cell1679–11. 10.1016/j.cell.2016.08.036

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 380

  Tomas A. Futter C. E. Eden E. R. (2014). EGF receptor trafficking: Consequences for signaling and cancer.Trends Cell Biol.2426–34.

  • Google Scholar

• 381

  Totaro A. Castellan M. Battilana G. Zanconato F. Azzolin L. Giulitti S. et al (2017). YAP/TAZ link cell mechanics to Notch signalling to control epidermal stem cell fate.Nat. Commun.8:15206. 10.1038/ncomms15206

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 382

  Totaro A. Castellan M. Di B. Piccolo S. (2018). Crosstalk between YAP/TAZ and Notch Signaling.Trends Cell Biol.28560–573.

  • Google Scholar

• 383

  Tsai B. P. Hoverter N. P. Waterman M. L. (2012). Blending hippo and WNT: Sharing messengers and regulation.Cell1511401–1403. 10.1016/j.cell.2012.12.007

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 384

  Tschaharganeh D. F. Chen X. Latzko P. Malz M. Gaida M. M. Felix K. et al (2013). Yes-associated protein up-regulates Jagged-1 and activates the Notch pathway in human hepatocellular carcinoma.Gastroenterology1441530–1542.e12. 10.1053/j.gastro.2013.02.009

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 385

  Tsivgoulis G. Kadlecová P. Kobayashi A. Czlonkowska A. Brozman M. Švigelj V. et al (2015). Safety of statin pretreatment in intravenous thrombolysis for acute ischemic stroke.Stroke462681–2684.

  • Google Scholar

• 386

  Tuo Q. Z. Liu Y. Xiang Z. Yan H. F. Zou T. Shu Y. et al (2022). Thrombin induces ACSL4-dependent ferroptosis during cerebral ischemia/reperfusion.Signal. Transduct. Target Ther.7:59. 10.1038/s41392-022-00917-z

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 387

  Udan R. S. Kango-Singh M. Nolo R. Tao C. Halder G. (2003). Hippo promotes proliferation arrest and apoptosis in the Salvador/Warts pathway.Nat. Cell. Biol.5914–920. 10.1038/ncb1050

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 388

  Uehata M. Ishizaki T. Satoh H. Ono T. Kawahara T. Morishita T. et al (1997). Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension.Nature389990–994.

  • Google Scholar

• 389

  Ugolini F. Charafe-Jauffret E. Bardou V. J. Geneix J. Adélaïde J. Labat-Moleur F. et al (2001). WNT pathway and mammary carcinogenesis: Loss of expression of candidate tumor suppressor gene SFRP1 in most invasive carcinomas except of the medullary type.Oncogene205810–5817. 10.1038/sj.onc.1204706

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 390

  Valente E. M. Abou-Sleiman P. M. Caputo V. Muqit M. M. Harvey K. Gispert S. et al (2004). Hereditary early-onset Parkinson’s disease caused by mutations in PINK1.Science3041158–1160.

  • Google Scholar

• 391

  Varelas X. Miller B. W. Sopko R. Song S. Gregorieff A. Fellouse F. A. et al (2010). The Hippo pathway regulates Wnt/beta-catenin signaling.Dev. Cell18579–591.

  • Google Scholar

• 392

  Varelas X. Sakuma R. Samavarchi-Tehrani P. Peerani R. Rao B. M. Dembowy J. et al (2008). TAZ controls Smad nucleocytoplasmic shuttling and regulates human embryonic stem-cell self-renewal.Nat. Cell Biol.10837–848. 10.1038/ncb1748

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 393

  Varjosalo M. Taipale J. (2008). Hedgehog: Functions and mechanisms.Genes Dev.222454–2472.

  • Google Scholar

• 394

  Veikkola T. Alitalo K. (1999). VEGFs, receptors and angiogenesis.Semin. Cancer Biol.9211–220.

  • Google Scholar

• 395

  Vousden K. H. Lu X. (2002). Live or let die: The cell’s response to p53.Nat. Rev. Cancer2594–604.

  • Google Scholar

• 396

  Vyas M. V. Silver F. L. Austin P. C. Yu A. Y. X. Pequeno P. Fang J. et al (2021). Stroke incidence by sex across the lifespan.Stroke52447–451.

  • Google Scholar

• 397

  Wabnitz A. Chimowitz M. (2017). Angioplasty, stenting and other potential treatments of atherosclerotic stenosis of the intracranial arteries: Past, present and future.J. Stroke19271–276. 10.5853/jos.2017.01837

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 398

  Wagner E. F. Nebreda A. R. (2009). Signal integration by JNK and p38 MAPK pathways in cancer development.Nat. Rev. Cancer9537–549.

  • Google Scholar

• 399

  Waldner M. J. Neurath M. F. (2012). Targeting the VEGF signaling pathway in cancer therapy.Expert. Opin. Ther. Targets165–13.

  • Google Scholar

• 400

  Wan D. Zhou Y. Wang K. Hou Y. Hou R. Ye X. (2016). Resveratrol provides neuroprotection by inhibiting phosphodiesterases and regulating the cAMP/AMPK/SIRT1 pathway after stroke in rats.Brain Res. Bull.121255–262. 10.1016/j.brainresbull.2016.02.011

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 401

  Wang G. Chen Z. Song Y. Wu H. Chen M. Lai S. et al (2022). Xueshuantong injection alleviates cerebral microcirculation disorder in middle cerebral artery occlusion/reperfusion rats by suppressing inflammation via JNK mediated JAK2/STAT3 and NF-κB signaling pathways.J. Ethnopharmacol.298:115592.

  • Google Scholar

• 402

  Wang H. Chen S. Zhang Y. Xu H. Sun H. (2019). Electroacupuncture ameliorates neuronal injury by Pink1/Parkin-mediated mitophagy clearance in cerebral ischemia-reperfusion.Nitric Oxide9123–34. 10.1016/j.niox.2019.07.004

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 403

  Wang H. Guo M. Wei H. Chen Y. (2023). Targeting p53 pathways: Mechanisms, structures, and advances in therapy.Signal. Transduct. Target Ther.8:92. 10.1038/s41392-023-01347-1

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 404

  Wang H. Xu X. Yin Y. Yu S. Ren H. Xue Q. et al (2020). Catalpol protects vascular structure and promotes angiogenesis in cerebral ischemic rats by targeting HIF-1α/VEGF.Phytomedicine78:153300.

  • Google Scholar

• 405

  Wang H. Ye K. Li D. Liu Y. Wang D. (2022). DL-3-n-butylphthalide for acute ischemic stroke: An updated systematic review and meta-analysis of randomized controlled trials.Front. Pharmacol.13:963118. 10.3389/fphar.2022.963118

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 406

  Wang L. P. Pan J. Li Y. Geng J. Liu C. Zhang L. Y. et al (2022). Oligodendrocyte precursor cell transplantation promotes angiogenesis and remyelination via Wnt/β-catenin pathway in a mouse model of middle cerebral artery occlusion.J. Cereb. Blood Flow Metab.42757–770.

  • Google Scholar

• 407

  Wang P. R. Wang J. S. Zhang C. Song X. F. Tian N. Kong L. Y. (2013). Huang-Lian-Jie-Du-Decotion induced protective autophagy against the injury of cerebral ischemia/reperfusion via MAPK-mTOR signaling pathway.J. Ethnopharmacol.149270–280. 10.1016/j.jep.2013.06.035

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 408

  Wang S. Shi X. Li H. Pang P. Pei L. Shen H. et al (2017). DAPK1 signaling pathways in stroke: From mechanisms to therapies.Mol. Neurobiol.544716–4722.

  • Google Scholar

• 409

  Wang S. Yin J. Ge M. Dai Z. Li Y. Si J. et al (2016). Transforming growth-beta 1 contributes to isoflurane postconditioning against cerebral ischemia-reperfusion injury by regulating the c-Jun N-terminal kinase signaling pathway.Biomed. Pharmacother.78280–290. 10.1016/j.biopha.2016.01.030

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 410

  Wang W. Li M. Wang Y. Li Q. Deng G. Wan J. et al (2016). GSK-3β inhibitor TWS119 attenuates rtPA-induced hemorrhagic transformation and activates the Wnt/β-catenin signaling pathway after acute ischemic stroke in rats.Mol. Neurobiol.537028–7036.

  • Google Scholar

• 411

  Wang X. Li X. Xu Y. Li R. Yang Q. Zhao Y. et al (2021). Effectiveness of intravenous r-tPA versus UK for acute ischaemic stroke: A nationwide prospective Chinese registry study.Stroke Vasc. Neurol.6603–609. 10.1136/svn-2020-000640

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 412

  Wang X. Pei L. Yan H. Wang Z. Wei N. Wang S. et al (2014). Intervention of death-associated protein kinase 1-p53 interaction exerts the therapeutic effects against stroke.Stroke453089–3091. 10.1161/STROKEAHA.114.006348

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 413

  Wang Y. Hong F. Yang S. (2022a). Roles of nitric oxide in brain ischemia and reperfusion.Int. J. Mol. Sci.23:4243.

  • Google Scholar

• 414

  Wang Y. Pan P. Wang Z. Zhang Y. Xie P. Geng D. et al (2017). β-catenin-mediated YAP signaling promotes human glioma growth.J. Exp. Clin. Cancer Res.36:136.

  • Google Scholar

• 415

  Wang Y. Zheng L. Shang W. Yang Z. Li T. Liu F. et al (2022b). Wnt/beta-catenin signaling confers ferroptosis resistance by targeting GPX4 in gastric cancer.Cell Death Differ.292190–2202. 10.1038/s41418-022-01008-w

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 416

  Wardlaw J. M. Murray V. Berge E. Del Z. (2014). Thrombolysis for acute ischaemic stroke.Cochrane Database Syst. Rev.2014:Cd000213. 10.3389/fmedt.2022.946367

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 417

  Wei R. Song L. Miao Z. Liu K. Han G. Zhang H. et al (2022). Hydroxysafflor yellow a exerts neuroprotective effects via HIF-1α/BNIP3 pathway to activate neuronal autophagy after OGD/R.Cells11:3726.

  • Google Scholar

• 418

  Wei Z. Chigurupati S. Arumugam T. V. Jo D. G. Li H. Chan S. L. (2011). Notch activation enhances the microglia-mediated inflammatory response associated with focal cerebral ischemia.Stroke422589–2594. 10.1161/STROKEAHA.111.614834

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 419

  Weiland A. Wang Y. Wu W. Lan X. Han X. Li Q. et al (2019). Ferroptosis and its role in diverse brain diseases.Mol. Neurobiol.564880–4893.

  • Google Scholar

• 420

  Wells A. (1999). EGF receptor.Int. J. Biochem. Cell Biol.31637–643.

  • Google Scholar

• 421

  Wharton K. A. Johansen K. M. Xu T. Artavanis-Tsakonas S. (1985). Nucleotide sequence from the neurogenic locus notch implies a gene product that shares homology with proteins containing EGF-like repeats.Cell43567–581. 10.1016/0092-8674(85)90229-6

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 422

  Whitman M. Downes C. P. Keeler M. Keller T. Cantley L. (1988). Type I phosphatidylinositol kinase makes a novel inositol phospholipid, phosphatidylinositol-3-phosphate.Nature332644–646. 10.1038/332644a0

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 423

  Willmot M. R. Bath P. M. (2003). The potential of nitric oxide therapeutics in stroke.Expert Opin. Investig. Drugs12455–470.

  • Google Scholar

• 424

  Wu F. Zhang Y. Sun B. Mcmahon A. P. Wang Y. (2017). Hedgehog signaling: From basic biology to cancer therapy.Cell Chem. Biol.24252–280.

  • Google Scholar

• 425

  Wu L. Wang H. M. Li J. L. Feng H. X. Zhao W. M. Zhang H. Y. (2017). Dual anti-ischemic effects of rosmarinic acid n-butyl ester via alleviation of DAPK-p53-mediated neuronal damage and microglial inflammation.Acta Pharmacol. Sin.38459–468. 10.1038/aps.2016.156

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 426

  Wu S. Huang J. Dong J. Pan D. (2003). hippo encodes a Ste-20 family protein kinase that restricts cell proliferation and promotes apoptosis in conjunction with salvador and warts.Cell114445–456. 10.1016/s0092-8674(03)00549-x

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 427

  Wu X. Li X. Liu Y. Yuan N. Li C. Kang Z. et al (2018). Hydrogen exerts neuroprotective effects on OGD/R damaged neurons in rat hippocampal by protecting mitochondrial function via regulating mitophagy mediated by PINK1/Parkin signaling pathway.Brain Res.169889–98. 10.1016/j.brainres.2018.06.028

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 428

  Xian M. Cai J. Zheng K. Liu Q. Liu Y. Lin H. et al (2021). Aloe-emodin prevents nerve injury and neuroinflammation caused by ischemic stroke via the PI3K/AKT/mTOR and NF-κB pathway.Food Funct.128056–8067.

  • Google Scholar

• 429

  Xiao G. Lyu M. Li Z. Cao L. Liu X. Wang Y. et al (2021). Restoration of early deficiency of axonal guidance signaling by guanxinning injection as a novel therapeutic option for acute ischemic stroke.Pharmacol. Res.165:105460. 10.1016/j.phrs.2021.105460

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 430

  Xie G. Liang Y. Gao W. Wu L. Zhang Y. Ye Z. et al (2023). Artesunate alleviates intracerebral haemorrhage secondary injury by inducing ferroptosis in M1-polarized microglia and suppressing inflammation through AMPK/mTORC1/GPX4 pathway.Basic Clin. Pharmacol. Toxicol.132369–383. 10.1111/bcpt.13848

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 431

  Xin N. Yang F. J. Li Y. Li Y. J. Dai R. J. Meng W. W. et al (2013). Dragon’s blood dropping pills have protective effects on focal cerebral ischemia rats model.Phytomedicine2168–74. 10.1016/j.phymed.2013.08.007

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 432

  Xu D. Hou K. Li F. Chen S. Fang W. Li Y. (2019). XQ-1H alleviates cerebral ischemia in mice through inhibition of apoptosis and promotion of neurogenesis in a Wnt/β-catenin signaling dependent way.Life Sci.235:116844.

  • Google Scholar

• 433

  Xu F. Na L. Li Y. Chen L. (2020). Roles of the PI3K/AKT/mTOR signalling pathways in neurodegenerative diseases and tumours.Cell Biosci.10:54.

  • Google Scholar

• 434

  Xu T. Wang W. Zhang S. Stewart R. A. Yu W. (1995). Identifying tumor suppressors in genetic mosaics: The Drosophila lats gene encodes a putative protein kinase.Development1211053–1063.

  • Google Scholar

• 435

  Xu Y. Zhang G. Kang Z. Xu Y. Jiang W. Zhang S. (2016). Cornin increases angiogenesis and improves functional recovery after stroke via the Ang1/Tie2 axis and the Wnt/β-catenin pathway.Arch. Pharm. Res.39133–142.

  • Google Scholar

• 436

  Xu Z. Ford B. D. (2005). Upregulation of erbB receptors in rat brain after middle cerebral arterial occlusion.Neurosci. Lett.375181–186. 10.1016/j.neulet.2004.11.039

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 437

  Yagita Y. Kitagawa K. Sasaki T. Terasaki Y. Todo K. Omura-Matsuoka E. et al (2007). Rho-kinase activation in endothelial cells contributes to expansion of infarction after focal cerebral ischemia.J. Neurosci. Res.852460–2469. 10.1002/jnr.21375

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 438

  Yamaguchi A. Taniguchi M. Hori O. Ogawa S. Tojo N. Matsuoka N. et al (2002). Peg3/Pw1 is involved in p53-mediated cell death pathway in brain ischemia/hypoxia.J. Biol. Chem.277623–629. 10.1074/jbc.M107435200

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 439

  Yan H. F. Zou T. Tuo Q. Z. Xu S. Li H. Belaidi A. A. et al (2021). Ferroptosis: Mechanisms and links with diseases.Signal. Transduct. Target Ther.6:49.

  • Google Scholar

• 440

  Yang A. Wu H. M. Tang J. L. Xu L. Yang M. Liu G. J. (2016). Acupuncture for stroke rehabilitation.Cochrane Database Syst. Rev.2016:Cd004131.

  • Google Scholar

• 441

  Yang B. Li Y. Ma Y. Zhang X. Yang L. Shen X. et al (2021). Selenium attenuates ischemia/reperfusion injury-induced damage to the blood-brain barrier in hyperglycemia through PI3K/AKT/mTOR pathway-mediated autophagy inhibition.Int. J. Mol. Med.48:178. 10.3892/ijmm.2021.5011

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 442

  Yang L. Tao L. Y. Chen X. P. (2007). Roles of NF-kappaB in central nervous system damage and repair.Neurosci. Bull.23307–313.

  • Google Scholar

• 443

  Yang S. Wang H. Yang Y. Wang R. Wang Y. Wu C. et al (2019). Baicalein administered in the subacute phase ameliorates ischemia-reperfusion-induced brain injury by reducing neuroinflammation and neuronal damage.Biomed. Pharmacother.117:109102. 10.1016/j.biopha.2019.109102

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 444

  Yang W. H. Ding C. C. Sun T. Rupprecht G. Lin C. C. Hsu D. et al (2019). The Hippo pathway effector TAZ regulates ferroptosis in renal cell carcinoma.Cell Rep.282501–2508.e4.

  • Google Scholar

• 445

  Yang W. S. Stockwell B. R. (2016). Ferroptosis: Death by lipid peroxidation.Trends Cell Biol.26165–176.

  • Google Scholar

• 446

  Yang W. S. Sriramaratnam R. Welsch M. E. Shimada K. Skouta R. Viswanathan V. S. et al (2014). Regulation of ferroptotic cancer cell death by GPX4.Cell156317–331.

  • Google Scholar

• 447

  Yang Y. He B. Zhang X. Yang R. Xia X. Chen L. et al (2022). Geraniin protects against cerebral ischemia/reperfusion injury by suppressing oxidative stress and neuronal apoptosis via regulation of the Nrf2/HO-1 pathway.Oxid. Med. Cell Longev.2022:2152746. 10.1155/2022/2152746

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 448

  Yeh S. H. Ou L. C. Gean P. W. Hung J. J. Chang W. C. (2011). Selective inhibition of early–but not late–expressed HIF-1α is neuroprotective in rats after focal ischemic brain damage.Brain Pathol.21249–262.

  • Google Scholar

• 449

  Yimlamai D. Christodoulou C. Galli G. G. Yanger K. Pepe-Mooney B. Gurung B. et al (2014). Hippo pathway activity influences liver cell fate.Cell1571324–1338. 10.1016/j.cell.2014.03.060

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 450

  Yochem J. Weston K. Greenwald I. (1988). The Caenorhabditis elegans lin-12 gene encodes a transmembrane protein with overall similarity to Drosophila Notch.Nature335547–550. 10.1038/335547a0

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 451

  Yonish-Rouach E. Resnitzky D. Lotem J. Sachs L. Kimchi A. Oren M. (1991). Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6.Nature352345–347.

  • Google Scholar

• 452

  Yu F. X. Zhao B. Panupinthu N. Jewell J. L. Lian I. Wang L. H. et al (2012). Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling.Cell150780–791. 10.1016/j.cell.2012.06.037

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 453

  Yu J. Wang W. N. Matei N. Li X. Pang J. W. Mo J. et al (2020). Ezetimibe attenuates oxidative stress and neuroinflammation via the AMPK/Nrf2/TXNIP pathway after MCAO in rats.Oxid. Med. Cell Longev.2020:4717258. 10.1155/2020/4717258

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 454

  Yu L. Liu Z. He W. Chen H. Lai Z. Duan Y. et al (2020). Hydroxysafflor yellow a confers neuroprotection from focal cerebral ischemia by modulating the crosstalk between JAK2/STAT3 and SOCS3 signaling pathways.Cell Mol. Neurobiol.401271–1281. 10.1007/s10571-020-00812-7

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 455

  Yu P. Wang L. Tang F. Guo S. Liao H. Fan C. et al (2021). Resveratrol-mediated neurorestoration after cerebral ischemic injury - Sonic Hedgehog signaling pathway.Life Sci.280:119715. 10.1016/j.lfs.2021.119715

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 456

  Yu P. Wang L. Tang F. Zeng L. Zhou L. Song X. et al (2017). Resveratrol pretreatment decreases ischemic injury and improves neurological function via sonic hedgehog signaling after stroke in rats.Mol. Neurobiol.54212–226. 10.1007/s12035-015-9639-7

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 457

  Yu Y. Li J. Zhou H. Xiong Y. Wen Y. Li H. (2018). Functional importance of the TGF-β1/Smad3 signaling pathway in oxygen-glucose-deprived (OGD) microglia and rats with cerebral ischemia.Int. J. Biol. Macromol.116537–544.

  • Google Scholar

• 458

  Yuan Y. Zhai Y. Chen J. Xu X. Wang H. (2021). Kaempferol ameliorates oxygen-glucose deprivation/reoxygenation-induced neuronal ferroptosis by activating Nrf2/SLC7A11/GPX4 axis.Biomolecules11:923. 10.3390/biom11070923

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 459

  Yuan Y. Zheng Y. Zhang X. Chen Y. Wu X. Wu J. et al (2017). BNIP3L/NIX-mediated mitophagy protects against ischemic brain injury independent of PARK2.Autophagy131754–1766. 10.1080/15548627.2017.1357792

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 460

  Zacharek A. Chen J. Cui X. Yang Y. Chopp M. (2009). Simvastatin increases notch signaling activity and promotes arteriogenesis after stroke.Stroke40254–260. 10.1161/STROKEAHA.108.524116

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 461

  Zanconato F. Cordenonsi M. Piccolo S. (2016). YAP/TAZ at the roots of cancer.Cancer Cell29783–803.

  • Google Scholar

• 462

  Zanin-Zhorov A. Weiss J. M. Nyuydzefe M. S. Chen W. Scher J. U. Mo R. et al (2014). Selective oral ROCK2 inhibitor down-regulates IL-21 and IL-17 secretion in human T cells via STAT3-dependent mechanism.Proc. Natl. Acad. Sci. U. S. A.11116814–16819. 10.1073/pnas.1414189111

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 463

  Zeng J. Zheng S. Chen Y. Qu Y. Xie J. Hong E. et al (2021). Puerarin attenuates intracerebral hemorrhage-induced early brain injury possibly by PI3K/Akt signal activation-mediated suppression of NF-κB pathway.J. Cell Mol. Med.257809–7824.

  • Google Scholar

• 464

  Zerlin M. Julius M. A. Kitajewski J. (2008). Wnt/Frizzled signaling in angiogenesis.Angiogenesis1163–69.

  • Google Scholar

• 465

  Zhan S. Liang J. Lin H. Cai J. Yang X. Wu H. et al (2022). SATB1/SLC7A11/HO-1 axis ameliorates ferroptosis in neuron cells after ischemic stroke by danhong injection.Mol. Neurobiol.60413–427. 10.1007/s12035-022-03075-z

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 466

  Zhang C. Tao W. Liu M. Wang D. (2012). Efficacy and safety of human urinary kallidinogenase injection for acute ischemic stroke: A systematic review.J. Evid. Based Med.531–39. 10.1111/j.1756-5391.2012.01167.x

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 467

  Zhang D. D. (2006). Mechanistic studies of the Nrf2-Keap1 signaling pathway.Drug Metab. Rev.38769–789.

  • Google Scholar

• 468

  Zhang W. Song J. K. Yan R. Li L. Xiao Z. Y. Zhou W. X. et al (2018). Diterpene ginkgolides protect against cerebral ischemia/reperfusion damage in rats by activating Nrf2 and CREB through PI3K/Akt signaling.Acta Pharmacol. Sin.391259–1272. 10.1038/aps.2017.149

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 469

  Zhang W. Song J. Li W. Kong D. Liang Y. Zhao X. et al (2020). Salvianolic acid D alleviates cerebral ischemia-reperfusion injury by suppressing the cytoplasmic translocation and release of HMGB1-triggered NF-κB activation to inhibit inflammatory response.Med. Inflamm.2020:9049614.

  • Google Scholar

• 470

  Zhang Y. Miao J. M. (2018). Ginkgolide K promotes astrocyte proliferation and migration after oxygen-glucose deprivation via inducing protective autophagy through the AMPK/mTOR/ULK1 signaling pathway.Eur. J. Pharmacol.83296–103. 10.1016/j.ejphar.2018.05.029

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 471

  Zhang Y. Janssens S. P. Wingler K. Schmidt H. H. Moens A. L. (2011). Modulating endothelial nitric oxide synthase: A new cardiovascular therapeutic strategy.Am. J. Physiol. Heart Circ. Physiol.301H634–H646.

  • Google Scholar

• 472

  Zhang Y. Liu D. Hu H. Zhang P. Xie R. Cui W. (2019). HIF-1α/BNIP3 signaling pathway-induced-autophagy plays protective role during myocardial ischemia-reperfusion injury.Biomed. Pharmacother.120:109464.

  • Google Scholar

• 473

  Zhang Y. Lu X. Tai B. Li W. Li T. (2021). Ferroptosis and Its Multifaceted Roles in Cerebral Stroke.Front. Cell Neurosci.15:615372. 10.3389/fncel.2021.615372

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 474

  Zhang Z. G. Zhang L. Jiang Q. Zhang R. Davies K. Powers C. et al (2000). VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain.J. Clin. Invest.106829–838.

  • Google Scholar

• 475

  Zhang Z. Yang X. Zhang S. Ma X. Kong J. (2007). BNIP3 upregulation and EndoG translocation in delayed neuronal death in stroke and in hypoxia.Stroke381606–1613. 10.1161/STROKEAHA.106.475129

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 476

  Zhao S. Yin J. Zhou L. Yan F. He Q. Huang L. et al (2016). Hippo/MST1 signaling mediates microglial activation following acute cerebral ischemia-reperfusion injury.Brain Behav. Immun.55236–248. 10.1016/j.bbi.2015.12.016

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 477

  Zhao X. Sun G. Zhang J. Ting S. M. Gonzales N. Aronowski J. (2015). Dimethyl Fumarate protects brain from damage produced by intracerebral hemorrhage by mechanism involving Nrf2.Stroke461923–1928. 10.1161/STROKEAHA.115.009398

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 478

  Zhao Y. Chen F. Chen S. Liu X. Cui M. Dong Q. (2013). The Parkinson’s disease-associated gene PINK1 protects neurons from ischemic damage by decreasing mitochondrial translocation of the fission promoter Drp1.J. Neurochem.127711–722. 10.1111/jnc.12340

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 479

  Zhao Y. Qian Y. Sun Z. Shen X. Cai Y. Li L. et al (2021). Role of PI3K in the progression and regression of atherosclerosis.Front. Pharmacol.12:632378. 10.3389/fphar.2021.632378

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 480

  Zheng Y. Pan D. (2019). The hippo signaling pathway in development and disease.Dev. Cell50264–282.

  • Google Scholar

• 481

  Zheng Y. Li R. Zhou Y. Zhang S. Fan X. (2022). Investigation on the potential targets of Astragaloside IV against intracerebral hemorrhage based on network pharmacology and experimental validation.Bioorg. Chem.127:105975. 10.1016/j.bioorg.2022.105975

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 482

  Zhong L. L. Zheng Y. Lau A. Y. Wong N. Yao L. Wu X. et al (2022). Would integrated Western and traditional Chinese medicine have more benefits for stroke rehabilitation? A systematic review and meta-analysis.Stroke Vasc. Neurol.777–85. 10.1136/svn-2020-000781

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 483

  Zhong W. J. Yang X. S. Zhou H. Xie B. R. Liu W. W. Li Y. (2022). Role of mitophagy in the pathogenesis of stroke: From mechanism to therapy.Oxid. Med. Cell Longev.2022:6232902.

  • Google Scholar

• 484

  Zhou G. Myers R. Li Y. Chen Y. Shen X. Fenyk-Melody J. et al (2001). Role of AMP-activated protein kinase in mechanism of metformin action.J. Clin. Invest.1081167–1174.

  • Google Scholar

• 485

  Zhou K. Chen J. Wu J. Wu Q. Jia C. Xu Y. X. Z. et al (2019). Atractylenolide III ameliorates cerebral ischemic injury and neuroinflammation associated with inhibiting JAK2/STAT3/Drp1-dependent mitochondrial fission in microglia.Phytomedicine59:152922. 10.1016/j.phymed.2019.152922

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 486

  Zhou Y. Liao J. Mei Z. Liu X. Ge J. (2021). Insight into crosstalk between ferroptosis and necroptosis: Novel therapeutics in ischemic stroke.Oxid. Med. Cell Longev.2021:9991001. 10.1155/2021/9991001

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 487

  Zhou Z. Q. Li Y. L. Ao Z. B. Wen Z. L. Chen Q. W. Huang Z. G. et al (2017). Baicalin protects neonatal rat brains against hypoxic-ischemic injury by upregulating glutamate transporter 1 via the phosphoinositide 3-kinase/protein kinase B signaling pathway.Neural Regen. Res.121625–1631. 10.4103/1673-5374.217335

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 488

  Zhou Z. X. Cui Q. Zhang Y. M. Yang J. X. Xiang W. J. Tian N. et al (2023). Withaferin A inhibits ferroptosis and protects against intracerebral hemorrhage.Neural Regen. Res.181308–1315. 10.4103/1673-5374.355822

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 489

  Zhu H. Jian Z. Zhong Y. Ye Y. Zhang Y. Hu X. et al (2021). Janus kinase inhibition ameliorates ischemic stroke injury and neuroinflammation through reducing NLRP3 inflammasome activation via JAK2/STAT3 pathway inhibition.Front. Immunol.12:714943. 10.3389/fimmu.2021.714943

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 490

  Zhu J. Cao D. Guo C. Liu M. Tao Y. Zhou J. et al (2019). Berberine facilitates angiogenesis against ischemic stroke through modulating microglial polarization via AMPK signaling.Cell Mol. Neurobiol.39751–768. 10.1007/s10571-019-00675-7

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 491

  Zhu T. Wang L. Wang L. P. Wan Q. (2022). Therapeutic targets of neuroprotection and neurorestoration in ischemic stroke: Applications for natural compounds from medicinal herbs.Biomed. Pharmacother.148:112719. 10.1016/j.biopha.2022.112719

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 492

  Zille M. Karuppagounder S. S. Chen Y. Gough P. J. Bertin J. Finger J. et al (2017). Neuronal death after hemorrhagic stroke in vitro and in vivo shares features of ferroptosis and necroptosis.Stroke481033–1043. 10.1161/STROKEAHA.116.015609

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 493

  Zolezzi J. M. Santos M. J. BASTíAS-Candia S. Pinto C. Godoy J. A. Inestrosa N. C. (2017). PPARs in the central nervous system: Roles in neurodegeneration and neuroinflammation.Biol. Rev. Camb. Philos. Soc.922046–2069.

  • Google Scholar